,para,label,document,predictions
147,"Synthesis & Characterization of O- and N-AlkTMMs
",0,data/dev/US20180072767A1.txt,1
172,"<img> id-US20180072767A1-20180315-C00024.TIF </img>
",0,data/dev/US20180072767A1.txt,1
173,"(A) Syntheses of alkyne- and azide-modified TMM reporters 1-4. a) TMSCl, Et3N; b) K2CO3, CH3OH (92% over two steps, ref. 31); c) carboxylic acid, DCC, DMAP, CH2Cl2; d) Dowex H+ resin, CH3OH (yields over two steps are given). (B) Syntheses of TCO- and fluorescein-modified TMM reporters 5 and 6. e) Pd/C, H2, CH3OH; f) NHS-TCO, Et3N, N,N'-dimethylformamide (DMF); g) FITC, Et3N, DMF; h) reaction of 8 with any commercially available amine-reactive reagent will provide access to custom TMM reporters.
",0,data/dev/US20180072767A1.txt,1
175,"6-O-(6-heptynoyl)-α,α-D-trehalose (O-AlkTMM or O-AlkTMM-CT)
",1,data/dev/US20180072767A1.txt,0
184,"Unlabeled probes for competition experiments: 6-O-(6-heptanoyl)-α,α-D-trehalose and N-(6-heptanoyl)-6-amino-6-deoxy-α,α-D-trehalose
",1,data/dev/US20180072767A1.txt,0
270,"<img> id-US20180072767A1-20180315-C00032.TIF </img>
",0,data/dev/US20180072767A1.txt,1
353,"Method:
",0,data/dev/US20200121691A1.txt,1
603,"Method 1
",0,data/dev/US20200121691A1.txt,1
623,"Method 2
",0,data/dev/US20200121691A1.txt,1
644,"Method 3
",0,data/dev/US20200121691A1.txt,1
705,"<img> id-US20200121691A1_00010.PNG </img>
",1,data/dev/US20200121691A1.txt,0
711,"<img> id-US20200121691A1_00011.PNG </img>
",1,data/dev/US20200121691A1.txt,0
713,"Example 1b
",0,data/dev/US20200121691A1.txt,1
717,"<img> id-US20200121691A1_00012.PNG </img>
",1,data/dev/US20200121691A1.txt,0
719,"Example 2a
",0,data/dev/US20200121691A1.txt,1
722,"<img> id-US20200121691A1_00013.PNG </img>
",1,data/dev/US20200121691A1.txt,0
725,"Example 2b
",0,data/dev/US20200121691A1.txt,1
728,"<img> id-US20200121691A1_00014.PNG </img>
",1,data/dev/US20200121691A1.txt,0
731,"Example 2c
",0,data/dev/US20200121691A1.txt,1
734,"<img> id-US20200121691A1_00015.PNG </img>
",1,data/dev/US20200121691A1.txt,0
737,"Example 2d
",0,data/dev/US20200121691A1.txt,1
740,"<img> id-US20200121691A1_00016.PNG </img>
",1,data/dev/US20200121691A1.txt,0
743,"Example 2e
",0,data/dev/US20200121691A1.txt,1
750,"Example 2f
",0,data/dev/US20200121691A1.txt,1
756,"Example 2g
",0,data/dev/US20200121691A1.txt,1
760,"<img> id-US20200121691A1_00019.PNG </img>
",1,data/dev/US20200121691A1.txt,0
763,"Example 2h
",0,data/dev/US20200121691A1.txt,1
766,"<img> id-US20200121691A1_00020.PNG </img>
",1,data/dev/US20200121691A1.txt,0
769,"Example 2i
",0,data/dev/US20200121691A1.txt,1
772,"<img> id-US20200121691A1_00021.PNG </img>
",1,data/dev/US20200121691A1.txt,0
775,"Example 2k
",0,data/dev/US20200121691A1.txt,1
782,"Example 2j
",0,data/dev/US20200121691A1.txt,1
788,"Example 2l
",0,data/dev/US20200121691A1.txt,1
791,"<img> id-US20200121691A1_00024.PNG </img>
",1,data/dev/US20200121691A1.txt,0
794,"Example 2m
",0,data/dev/US20200121691A1.txt,1
797,"<img> id-US20200121691A1_00025.PNG </img>
",1,data/dev/US20200121691A1.txt,0
799,"Example 3a
",0,data/dev/US20200121691A1.txt,1
804,"Example 3b
",0,data/dev/US20200121691A1.txt,1
809,"Example 3c
",0,data/dev/US20200121691A1.txt,1
812,"<img> id-US20200121691A1_00028.PNG </img>
",1,data/dev/US20200121691A1.txt,0
814,"Example 3d
",0,data/dev/US20200121691A1.txt,1
819,"Example 3e
",0,data/dev/US20200121691A1.txt,1
825,"Example 3f
",0,data/dev/US20200121691A1.txt,1
830,"Example 3g
",0,data/dev/US20200121691A1.txt,1
836,"Example 3h
",0,data/dev/US20200121691A1.txt,1
841,"Example 3i
",0,data/dev/US20200121691A1.txt,1
846,"Example 3k
",0,data/dev/US20200121691A1.txt,1
852,"Example 3j
",0,data/dev/US20200121691A1.txt,1
857,"Example 3l
",0,data/dev/US20200121691A1.txt,1
862,"Example 3m
",0,data/dev/US20200121691A1.txt,1
867,"Example 4a
",0,data/dev/US20200121691A1.txt,1
872,"Example 4b
",0,data/dev/US20200121691A1.txt,1
877,"Example 4c
",0,data/dev/US20200121691A1.txt,1
882,"Example 4d
",0,data/dev/US20200121691A1.txt,1
887,"Example 4e
",0,data/dev/US20200121691A1.txt,1
892,"Example 4f
",0,data/dev/US20200121691A1.txt,1
897,"Example 4g
",0,data/dev/US20200121691A1.txt,1
902,"Example 4h
",0,data/dev/US20200121691A1.txt,1
907,"Example 4i
",0,data/dev/US20200121691A1.txt,1
912,"Example 4k
",0,data/dev/US20200121691A1.txt,1
918,"Example 4j
",0,data/dev/US20200121691A1.txt,1
923,"Example 4l
",0,data/dev/US20200121691A1.txt,1
928,"Example 4m
",0,data/dev/US20200121691A1.txt,1
931,"Example 1
",1,data/dev/US20200121691A1.txt,0
938,"Example 2
",1,data/dev/US20200121691A1.txt,0
946,"Example 3
",1,data/dev/US20200121691A1.txt,0
954,"Example 4
",1,data/dev/US20200121691A1.txt,0
966,"Example 5
",0,data/dev/US20200121691A1.txt,1
974,"Example 6
",0,data/dev/US20200121691A1.txt,1
982,"Example 7
",0,data/dev/US20200121691A1.txt,1
990,"Example 8
",0,data/dev/US20200121691A1.txt,1
998,"Example 9
",0,data/dev/US20200121691A1.txt,1
1006,"Example 18
",0,data/dev/US20200121691A1.txt,1
1013,"Example 30
",0,data/dev/US20200121691A1.txt,1
1021,"Example 3l
",0,data/dev/US20200121691A1.txt,1
1029,"Example 33
",0,data/dev/US20200121691A1.txt,1
1037,"Example 34
",0,data/dev/US20200121691A1.txt,1
1045,"Example 35
",0,data/dev/US20200121691A1.txt,1
1053,"Example 36
",0,data/dev/US20200121691A1.txt,1
1134,"Example 1: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1135,"<img> id-imgb0020.tif </img>
",0,data/dev/EP3323817A1.txt,1
1157,"Example 2: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(2-oxo -2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1158,"<img> id-imgb0028.tif </img>
",0,data/dev/EP3323817A1.txt,1
1168,"Example 3: N-(5-(5-chloro-4-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1 -yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1169,"<img> id-imgb0032.tif </img>
",0,data/dev/EP3323817A1.txt,1
1191,"Example 4: N-(5-(5-chloro-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1 -yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1192,"<img> id-imgb0040.tif </img>
",0,data/dev/EP3323817A1.txt,1
1197,"<img> id-imgb0042.tif </img>1H NMR (CDCl3): δ 8.94 (1H, s), 8.66 (1H, s), 8.38 (1H, br), 7.84 (1H, s), 7.23-7.13 (4H, m), 4.05 (3H, s), 3.56 (2H, br), 3.08 (2H, br), 2.89 (3H, s) 2.69 (6H, s).
",1,data/dev/EP3323817A1.txt,0
1198,"The title compound was prepared from 1-(5-chloro-2-(4-fluoro-2-methoxy-5 -nitrophenylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one by a method similar to that described in Step 5 of Example 1.
",0,data/dev/EP3323817A1.txt,1
1202,"Example 5: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(2 -oxobenzo[d]oxazol-3(2H)-yl)pyrimidin-2-ylamino)phenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1203,"<img> id-imgb0044.tif </img>
",0,data/dev/EP3323817A1.txt,1
1222,"Example 6: N-(2-((2-hydroxyethyl)(methyl)amino)-4-methoxy-5-(4-(3-methyl-2 -oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide
",0,data/dev/EP3323817A1.txt,1
1223,"<img> id-imgb0051.tif </img>
",0,data/dev/EP3323817A1.txt,1
1233,"Example 8: N-(4-methoxy-5-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]midazol-1-yl) pyrimidin-2-ylamino)-2-morpholinophenyl)acrylamide
",0,data/dev/EP3323817A1.txt,1
1234,"<img> id-imgb0055.tif </img>
",0,data/dev/EP3323817A1.txt,1
1241,"Example 9: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(5-methyl-2-oxo-2,3-dihydrobenzo [d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1242,"<img> id-imgb0058.tif </img>
",0,data/dev/EP3323817A1.txt,1
1258,"Example 10: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-(4-(5-fluoro-3 -methyl-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1278,"Example 11: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-(4-(5-fluoro-2-oxo -2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)-4-methoxyphenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1279,"<img> id-imgb0071.tif </img>
",0,data/dev/EP3323817A1.txt,1
1289,"Example 12: N-(4-methoxy-2-(methyl(2-(methylamino)ethyl)amino)-5-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d|imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1290,"<img> id-imgb0075.tif </img>
",0,data/dev/EP3323817A1.txt,1
1303,"Example 14: N-(5-(4-(5-chloro-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole -1-yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1315,"<img> id-imgb0084.tif </img>
",1,data/dev/EP3323817A1.txt,0
1326,"Example 15: N-(5-(4-(5-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole -1-yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1327,"<img> id-imgb0088.tif </img>
",0,data/dev/EP3323817A1.txt,1
1332,"<img> id-imgb0090.tif </img>
",1,data/dev/EP3323817A1.txt,0
1341,"<img> id-imgb0093.tif </img>
",1,data/dev/EP3323817A1.txt,0
1344,"<img> id-imgb0094.tif </img>
",1,data/dev/EP3323817A1.txt,0
1464,"ZD002 & (2-chloro-5-(pyridin-2-ethynyl)phenyl)(7-oxa-2-aza-spiro[3.5]nonan-2-yl)methanone & <img> id-imgb0020.tif </img>
",0,data/dev/EP3284738A1.txt,1
1465,"ZD003 & (2-chloro-5-(pyridin-2-ethynyl)phenyl)(8-oxa-2-aza-spiro[4.5]dec-2-yl)methanone & <img> id-imgb0021.tif </img>
",0,data/dev/EP3284738A1.txt,1
1466,"ZD004 & 2-fluoro-N-(4-fluorophenyl)-5-((2-methylt hiazol-4-yl)ethynyl)benzamide & <img> id-imgb0022.tif </img>
",0,data/dev/EP3284738A1.txt,1
1470,"ZD008 & (3-((2-methylthiazol-4-yl)phenyl)(8-oxa-2 -aza-spiro[4.5]dec-2-yl)methanone & <img> id-imgb0026.tif </img>
",0,data/dev/EP3284738A1.txt,1
1471,"ZD009 & N-(4-fluorophenyl)-3-((2-methylthiazol-4-yl)ethynyl)benzamide & <img> id-imgb0027.tif </img>
",0,data/dev/EP3284738A1.txt,1
1473,"ZD011 & (1-methyl-3,4-dihydro-isoquinolin-2(1H)-yl-3-((2-methyl-thiazol-4-yl)ethynyl)phen yl)methanone & <img> id-imgb0029.tif </img>
",0,data/dev/EP3284738A1.txt,1
1492,"ZD048 & (2-fluoro-5-(pyridin-2-ylethynyl)phenyl)( 1-methyl-3,4-dihydro-isoquinolin-2(1H)-y l)methanone & <img> id-imgb0048.tif </img>
",0,data/dev/EP3284738A1.txt,1
1560,"Example 1 The preparation of 2-fluoro-5- (pyridin-2-ethynyl) -N- (4-fluorophenyl) benzamide (ZD001)
",0,data/dev/EP3284738A1.txt,1
1561,"1.1 Synthesis of 2-fluoro-5-iodo-benzoyl chloride
",1,data/dev/EP3284738A1.txt,0
1563,"1.2 Synthesis of 2-fluoro-N-(4-fluorophenyl)-5-iodobenzamide
",1,data/dev/EP3284738A1.txt,0
1565,"1.3 Synthesis of final product ZD001
",1,data/dev/EP3284738A1.txt,0
1625,"Example 31 The preparation of 4-((2-methylthiazol-4-yl)ethynyl)-2-(1,2,3,4-dihydroisoquinoline-2-carbonyl)benzonitrile (ZD062)
",1,data/dev/EP3284738A1.txt,0
2104,"(Example 2) Production of the Compound Represented by Formula (I-61)
",1,data/dev/US20180002276A1.txt,0
2106,"The compounds represented by Formula (I-61-1) to (I-61) were prepared as in Example 1.
",1,data/dev/US20180002276A1.txt,0
2108,"(Example 3) Production of the Compound Represented by Formula (I-67)
",1,data/dev/US20180002276A1.txt,0
2110,"The compounds represented by Formula (I-67-1) to (I-67) were prepared as in Example 1. MS (m/z): 1167 [M++1]
",1,data/dev/US20180002276A1.txt,0
2112,"<img> id-US20180002276A1-20180104-C00102.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2183,"<img> id-US20180002276A1-20180104-C00119.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2261,"<img> id-US20200048291A1_00026.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2264,"<img> id-US20200048291A1_00027.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2281,"<img> id-US20200048291A1_00029.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2292,"<img> id-US20200048291A1_00030.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2523,"The BPI (1,3-Bis(2-pyridylimino)isoindoline), benz(f)BPI (3-Bis(2-pyridylimino)benz(f)isoindoline) and Pt(BPI)Cl were synthesized according to reported procedures. [47]
",0,data/dev/US20200048291A1.txt,1
2568,"After extracting the crude product into dichloromethane layer, it was purified by recrystallization by diffusing diethyl ether into acetonitrile. Reddish yellow crystal was obtained.
",1,data/dev/US20200048291A1.txt,0
2698,"<img> id-US20200270285A1_00010.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2703,"<img> id-US20200270285A1_00011.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2706,"<img> id-US20200270285A1_00012.PNG </img><img> id-US20200270285A1_00013.PNG </img><img> id-US20200270285A1_00014.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2708,"<img> id-US20200270285A1_00015.PNG </img><img> id-US20200270285A1_00016.PNG </img><img> id-US20200270285A1_00017.PNG </img><img> id-US20200270285A1_00018.PNG </img><img> id-US20200270285A1_00019.PNG </img><img> id-US20200270285A1_00020.PNG </img><img> id-US20200270285A1_00021.PNG </img><img> id-US20200270285A1_00022.PNG </img><img> id-US20200270285A1_00023.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2749,"Example 1-1
",1,data/dev/US20200270285A1.txt,0
2753,"<img> id-US20200270285A1_00024.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2754,"Example 1-2
",1,data/dev/US20200270285A1.txt,0
2758,"<img> id-US20200270285A1_00025.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2759,"Example 1-3
",1,data/dev/US20200270285A1.txt,0
2763,"<img> id-US20200270285A1_00026.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2764,"Example 1-4
",1,data/dev/US20200270285A1.txt,0
2768,"<img> id-US20200270285A1_00027.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2769,"Example 1-5
",1,data/dev/US20200270285A1.txt,0
2773,"<img> id-US20200270285A1_00028.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2774,"Example 1-6
",1,data/dev/US20200270285A1.txt,0
2778,"<img> id-US20200270285A1_00029.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2779,"Example 1-7
",1,data/dev/US20200270285A1.txt,0
2783,"<img> id-US20200270285A1_00030.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2784,"Example 1-8
",1,data/dev/US20200270285A1.txt,0
2788,"<img> id-US20200270285A1_00031.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2789,"Example 1-9
",1,data/dev/US20200270285A1.txt,0
2793,"<img> id-US20200270285A1_00032.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2794,"Example 1-10
",1,data/dev/US20200270285A1.txt,0
2798,"<img> id-US20200270285A1_00033.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2799,"Example 1-11
",1,data/dev/US20200270285A1.txt,0
2803,"<img> id-US20200270285A1_00034.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2804,"Example 1-12
",1,data/dev/US20200270285A1.txt,0
2808,"<img> id-US20200270285A1_00035.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2809,"Example 1-13
",1,data/dev/US20200270285A1.txt,0
2813,"<img> id-US20200270285A1_00036.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2814,"Example 1-14
",1,data/dev/US20200270285A1.txt,0
2818,"<img> id-US20200270285A1_00037.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2819,"Example 1-15
",1,data/dev/US20200270285A1.txt,0
2823,"<img> id-US20200270285A1_00038.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2824,"Example 1-16
",1,data/dev/US20200270285A1.txt,0
2828,"<img> id-US20200270285A1_00039.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2830,"<img> id-US20200270285A1_00040.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2832,"Example 1-17
",1,data/dev/US20200270285A1.txt,0
2836,"<img> id-US20200270285A1_00041.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2838,"<img> id-US20200270285A1_00042.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2852,"<img> id-US20200270285A1_00043.PNG </img>
",0,data/dev/US20200270285A1.txt,1
3091,"After completion of the reaction, water may be added to the reaction mixtures, the mixture is extracted with an organic solvent(s), and if necessary, the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite, and sodium thiosulfate) and an aqueous solution of a base (for example, sodium hydrogen carbonate). The organic layer may be dried and concentrated to obtain the compound (Ib).
",0,data/dev/US20200165244A1.txt,1
3100,"After completion of the reaction, water may be added to the reaction mixtures, the mixture is extracted with an organic solvent(s), and if necessary, the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite, and sodium thiosulfate) and an aqueous solution of a base (for example, sodium hydrogen carbonate). The organic layer may be dried and concentrated to obtain the compound (Ic).
",0,data/dev/US20200165244A1.txt,1
3198," & H & Me
",0,data/dev/US20200165244A1.txt,1
3199," & H & Et
",0,data/dev/US20200165244A1.txt,1
3200," & H & Pr
",0,data/dev/US20200165244A1.txt,1
3201," & H & i-Pr
",0,data/dev/US20200165244A1.txt,1
3203," & H & i-Bu
",0,data/dev/US20200165244A1.txt,1
3210," & Me & Me
",0,data/dev/US20200165244A1.txt,1
3211," & Me & Et
",0,data/dev/US20200165244A1.txt,1
3212," & Me & Pr
",0,data/dev/US20200165244A1.txt,1
3213," & Me & i-Pr
",0,data/dev/US20200165244A1.txt,1
3237," & c-Pr & Me
",0,data/dev/US20200165244A1.txt,1
3238," & c-Pr & Et
",0,data/dev/US20200165244A1.txt,1
3239," & c-Pr & Pr
",0,data/dev/US20200165244A1.txt,1
3240," & c-Pr & i-Pr
",0,data/dev/US20200165244A1.txt,1
3241," & c-Pr & Bu
",0,data/dev/US20200165244A1.txt,1
3242," & c-Pr & i-Bu
",0,data/dev/US20200165244A1.txt,1
3243," & c-Pr & s-Bu
",0,data/dev/US20200165244A1.txt,1
3244," & c-Pr & t-Bu
",0,data/dev/US20200165244A1.txt,1
3247," & c-Pr & 4-OMe-Bn
",0,data/dev/US20200165244A1.txt,1
3248," & c-Pr & 4-NO2-Bn
",0,data/dev/US20200165244A1.txt,1
3249," & C(O)OMe & Me
",0,data/dev/US20200165244A1.txt,1
3250," & C(O)OEt & Et
",0,data/dev/US20200165244A1.txt,1
3251," & C(O)OPr & Pr
",0,data/dev/US20200165244A1.txt,1
3252," & C(O)Oi-Pr & i-Pr
",0,data/dev/US20200165244A1.txt,1
3285," & Me & Me
",0,data/dev/US20200165244A1.txt,1
3286," & Et & Et
",0,data/dev/US20200165244A1.txt,1
3287," & Pr & Pr
",0,data/dev/US20200165244A1.txt,1
3289," & H & Et
",0,data/dev/US20200165244A1.txt,1
3290," & H & Pr
",0,data/dev/US20200165244A1.txt,1
3315," & Me & Et
",0,data/dev/US20200165244A1.txt,1
3316," & Me & Pr
",0,data/dev/US20200165244A1.txt,1
3327," & —CH2CH2CH2CH2CH2—
",0,data/dev/US20200165244A1.txt,1
3370,"1-methylcyclopropene+SX, 2,3,5-triiodobenzoic acid+SX, IAA ((1H-indol-3-yl)acetic acid)+SX, IBA (4-(1H-indol-3-yl)butyric acid) SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid)+SX, MCPB (4-(4-chloro-2-methylphenoxy)butyric acid) SX, 4-CPA (4-chlorophenoxyacetic acid) SX, 5-aminolevulinic acid hydrochloride+SX, 6-benzylaminopurine+SX, abscisic acid+SX, AVG (aminoethoxyvinylglycine)+SX, ancymidol+SX, butralin+SX, calcium carbonate+SX, calcium chloride+SX, calcium formate+SX, calcium peroxide+SX, calcium polysulfide+SX, calcium sulfate+SX, chlormequat-chloride+SX, chlorpropham+SX, choline chloride+SX, cloprop+SX, cyanamide+SX, cyclanilide+SX, daminozide+SX, decan-1-ol+SX, dichlorprop+SX, dikegulac+SX, dimethipin+SX, diquat+SX, ethephon SX, ethychlozate+SX, flumetralin+SX, flurprimidol+SX, forchlorfenuron+SX, Gibberellin A+SX, Gibberellin A3+SX, inabenfide+SX, Kinetin+SX, maleic hydrazide+SX, mefluidide+SX, mepiquat-chloride SX, oxidized glutathione SX, pacrobutrazol SX, pendimethalin SX, prohexandione-calcium+SX, prohydrojasmon+SX, pyraflufen-ethyl+SX, sintofen+SX, sodium 1-naphthaleneacetate+SX, sodium cyanate+SX, streptmycin+SX, thidiazuron SX, triapenthenol+SX, Tribufos+SX, trinexapac-ethyl+SX, uniconazole-P+SX, 2-(naphthalene-1-yl)acetamide+SX, [4-oxo-4-(2-phenylethyl)amino]butyric acid+SX, methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate+SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]-1-propanol+SX, Glomus spp.+SX, Glomus intraradices+SX, Glomus mosseae SX, Glomus aggregatum+SX, Glomus etunicatum+SX, Bradyrhizobium elkani+SX, Bradyrhizobium japonicum+SX, Bradyrhizobium lupini SX, Rhizobium leguminosarum bv. trifolii+SX, Rhizobium leguminosarum bv. phaseoli+SX, Rhizobium leguminosarum bv. viciae+SX, Sinorhizobium meliloti+SX, Rhizobium spp.+SX.
",0,data/dev/US20200165244A1.txt,1
3374,"1-dodecyl-1H-imidazole+SX, N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide+SX, bucarpolate+SX, N,N-dibutyl-4-chlorobenzenesulfonamide+SX, dietholate+SX, diethylmaleate+SX, piperonyl butoxide+SX, piperonyl cyclonene+SX, piprotal+SX, propyl isome+SX, safroxan+SX, sesamex+SX, sesamolin+SX, sulfoxide+SX, Verbutin+SX, DMC (1,1-bis(4-chlorophenyl)ethanol)+SX, FDMC (1,1-bis(4-chlorophenyl)-2,2,2-trifluoroethanol)+SX, ETN (1,2-epoxy-1,2,3,4-tetrahydronaphthalene)+SX, ETP (1,1,1-trichloro-2,3-expoxypropane)+SX, PSCP (phenylsaligenin cyclic phosphate) SX, TBPT (S,S,S-tributyl phosphorotrithioate)+SX, TPP (triphenyl phosphate)+SX.
",0,data/dev/US20200165244A1.txt,1
3549,"Preparation Example 1
",1,data/dev/US20200165244A1.txt,0
3551,"<img> id-US20200165244A1_00020.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3555,"Preparation Example 2
",1,data/dev/US20200165244A1.txt,0
3557,"<img> id-US20200165244A1_00022.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3559,"Preparation Example 3
",1,data/dev/US20200165244A1.txt,0
3561,"<img> id-US20200165244A1_00023.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3563,"Preparation Example 4
",1,data/dev/US20200165244A1.txt,0
3565,"<img> id-US20200165244A1_00024.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3567,"Preparation Example 5
",1,data/dev/US20200165244A1.txt,0
3569,"<img> id-US20200165244A1_00025.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3571,"Preparation Example 6
",1,data/dev/US20200165244A1.txt,0
3573,"<img> id-US20200165244A1_00026.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3593," & A2 & NBoc2
",1,data/dev/US20200165244A1.txt,0
3594," & A4 & NHC(O)OMe
",1,data/dev/US20200165244A1.txt,0
3596," & A8 & <img> id-US20200165244A1_00028.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3598," & A9 & <img> id-US20200165244A1_00029.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3605,"Preparation Example 8
",1,data/dev/US20200165244A1.txt,0
3607,"<img> id-US20200165244A1_00030.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3627," & A4 & C(O)OMe & H
",1,data/dev/US20200165244A1.txt,0
3628," & A6 & C(O)OPr & H
",1,data/dev/US20200165244A1.txt,0
3634,"<img> id-US20200165244A1_00032.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3636,"Preparation Example 11
",1,data/dev/US20200165244A1.txt,0
3637,"The compound A5 which was prepared according to the method described in Preparation Example 10 and physical property value thereof is shown below.
",1,data/dev/US20200165244A1.txt,0
3638,"<img> id-US20200165244A1_00033.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3640,"Preparation Example 12
",1,data/dev/US20200165244A1.txt,0
3642,"<img> id-US20200165244A1_00034.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3643,"Preparation Example 13
",1,data/dev/US20200165244A1.txt,0
3645,"<img> id-US20200165244A1_00035.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3647,"Preparation Example 14
",0,data/dev/US20200165244A1.txt,1
3650,"<img> id-US20200165244A1_00036.PNG </img>
",0,data/dev/US20200165244A1.txt,1
3666," & C3 & H & C(O)OMe
",1,data/dev/US20200165244A1.txt,0
3866,"2) performing a dihydroxylation reaction on the product of step 1) to synthesize a diol compound;
",0,data/dev/US20200123187A1.txt,1
3883,"1) adding NaH, DMF and an alkyl iodide to (E)-but-2-ene-1,4-diol and performing a dialkylation reaction to obtain a compound A.
",0,data/dev/US20200123187A1.txt,1
3918,"<1-2′> Typical synthesis procedure for Upjohn dihydroxylation (Step b in FIG. 2)
",1,data/dev/US20200123187A1.txt,0
3920,"<1-3> Typical Synthesis Procedure for Glycosylation Reaction (Step d in FIG. 1 and Step c in FIG. 2)
",1,data/dev/US20200123187A1.txt,0
3924,"<Preparative Example 1> Synthesis of B-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3933,"<Preparative Example 2> Synthesis of B-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3942,"<Preparative Example 3> Synthesis of B-BTM-C11
",0,data/dev/US20200123187A1.txt,1
3951,"<Preparative Example 4> Synthesis of A-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3960,"<Preparative Example 5> Synthesis of A-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3969,"<Preparative Example 6> Synthesis of A-BTM-C11
",0,data/dev/US20200123187A1.txt,1
3978,"<Preparative Example 7> Synthesis of M-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3987,"<Preparative Example 8> Synthesis of M-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3996,"<Preparative Example 9> Synthesis of M-BTM-C11
",0,data/dev/US20200123187A1.txt,1
4136,"Example 1: Preparation of 1-(trans-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4153,"<img> id-US20200308177A1_00006.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4157,"<img> id-US20200308177A1_00007.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4161,"<img> id-US20200308177A1_00008.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4164,"<img> id-US20200308177A1_00009.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4168,"<img> id-US20200308177A1_00010.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4172,"<img> id-US20200308177A1_00011.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4176,"<img> id-US20200308177A1_00012.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4180,"<img> id-US20200308177A1_00013.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4184,"<img> id-US20200308177A1_00014.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4188,"<img> id-US20200308177A1_00015.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4192,"<img> id-US20200308177A1_00016.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4196,"<img> id-US20200308177A1_00017.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4200,"<img> id-US20200308177A1_00018.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4204,"<img> id-US20200308177A1_00019.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4208,"<img> id-US20200308177A1_00020.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4212,"<img> id-US20200308177A1_00021.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4216,"<img> id-US20200308177A1_00022.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4219,"Example 19: Preparation of 1-((3S,4R)-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4233,"<img> id-US20200308177A1_00024.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4237,"<img> id-US20200308177A1_00025.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4241,"<img> id-US20200308177A1_00026.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4244,"Example 23: Preparation of 1-(trans-4-fluoro-3-((2-(isoxazol-4-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)piperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4261,"<img> id-US20200308177A1_00028.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4265,"<img> id-US20200308177A1_00029.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4269,"<img> id-US20200308177A1_00030.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4273,"<img> id-US20200308177A1_00031.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4276,"Example 28: Preparation of 1-((3R,4S)-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4294,"<img> id-US20200308177A1_00033.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4298,"<img> id-US20200308177A1_00034.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4302,"<img> id-US20200308177A1_00035.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4306,"<img> id-US20200308177A1_00036.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4310,"<img> id-US20200308177A1_00037.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4314,"<img> id-US20200308177A1_00038.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4318,"<img> id-US20200308177A1_00039.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4321,"Example 36: Preparation of 1-((3S,4R)-4-fluoro-3-((2-((1-(piperidin-4-yl)-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)piperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4525,"<img> id-US20200148885A1_00022.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4607,"<img> id-US20200148885A1_00027.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4749,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 407 (M+H), Elemental analysis values: CHN measurement values (85.47%, 8.02%, 6.72%); theoretical values (85.26%, 8.11%, 6.63%)
",0,data/dev/US20200148885A1.txt,1
4754,"<img> id-US20200148885A1_00029.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4761,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (EST) (m/z): 407 (M+H), Elemental analysis values: CHN measurement values (85.47%, 8.02%, 6.72%); theoretical values (85.26%, 8.11%, 6.63%)
",0,data/dev/US20200148885A1.txt,1
4762,"<img> id-US20200148885A1_00031.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4765,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 449 (M+H), Elemental analysis values: CHN measurement values (82.90%, 7.33%, 6.22%); theoretical values (82.81%, 7.40%, 6.23%)
",0,data/dev/US20200148885A1.txt,1
4766,"<img> id-US20200148885A1_00032.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4769,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 477 (M+H), Elemental analysis values: CHN measurement values (83.23%, 7.55%, 5.84%); theoretical values (83.15%, 7.61%, 5.88%)
",0,data/dev/US20200148885A1.txt,1
4770,"<img> id-US20200148885A1_00033.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4773,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 505 (M+H), Elemental analysis values: CHN measurement values (83.39%, 7.91%, 5.54%); theoretical values (83.29%, 7.99%, 5.55%)
",0,data/dev/US20200148885A1.txt,1
4774,"<img> id-US20200148885A1_00034.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4777,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 461 (M+H), Elemental analysis values: CHN measurement values (80.89%, 9.60%, 6.05%); theoretical values (80.82%, 9.63%, 6.08%)
",0,data/dev/US20200148885A1.txt,1
4779,"Synthesis Example 9: Synthesis of Compound 1-1
",1,data/dev/US20200148885A1.txt,0
4781,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 635 (+), divalent Elemental analysis values: CHN measurement values (81.59%, 6.85%, 5.25%); theoretical values (81.53%, 6.92%, 5.29%)
",0,data/dev/US20200148885A1.txt,1
4782,"<img> id-US20200148885A1_00036.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4785,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 663(+), divalent Elemental analysis values: CHN measurement values (81.75%, 7.17%, 5.99%); theoretical values (81.69%, 7.22%, 6.02%)
",0,data/dev/US20200148885A1.txt,1
4786,"<img> id-US20200148885A1_00037.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4787,"Synthesis Example 11: Synthesis of Compound 1-3
",1,data/dev/US20200148885A1.txt,0
4792,"<img> id-US20200148885A1_00038.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4795,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 538(+), divalent Elemental analysis values: CHN measurement values (73.51%, 8.02%, 7.28%); theoretical values (78.43%, 8.07%, 7.32%)
",0,data/dev/US20200148885A1.txt,1
4796,"<img> id-US20200148885A1_00039.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4797,"Synthesis Example 13: Synthesis of Compound 1-5
",1,data/dev/US20200148885A1.txt,0
4799,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 552(+), divalent Elemental analysis values: CHN measurement values (78.68%, 8.17%, 7.10%); theoretical values (78.61%, 8.22%, 7.14%)
",0,data/dev/US20200148885A1.txt,1
4800,"<img> id-US20200148885A1_00040.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4801,"Synthesis Example 14: Synthesis of Compound 1-6
",1,data/dev/US20200148885A1.txt,0
4803,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 691(+), divalent Elemental analysis values: CHN measurement values (81.91%, 7.44%, 5.72%); theoretical values (81.84%, 7.49%, 5.78%)
",0,data/dev/US20200148885A1.txt,1
4804,"<img> id-US20200148885A1_00041.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4805,"Synthesis Example 15: Synthesis of Compound 1-7
",1,data/dev/US20200148885A1.txt,0
4807,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 691(+), divalent Elemental analysis values: CHN measurement values (81.90%, 7.44%, 5.74%); theoretical values (81.84%, 7.49%, 5.78%)
",0,data/dev/US20200148885A1.txt,1
4808,"<img> id-US20200148885A1_00042.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4809,"Synthesis Example 16: Synthesis of Compound 1-8
",1,data/dev/US20200148885A1.txt,0
4811,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 719(+), divalent Elemental analysis values: CHN measurement values (81.97%, 7.55%, 5.65%); theoretical values (81.91%, 7.62%, 5.67%)
",0,data/dev/US20200148885A1.txt,1
4812,"<img> id-US20200148885A1_00043.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4813,"Synthesis Example 17: Synthesis of Compound 1-9
",1,data/dev/US20200148885A1.txt,0
4815,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 675(+), divalent Elemental analysis values: CHN measurement values (80.38%, 8.73%, 5.85%); theoretical values (80.30%, 8.80%, 5.91%)
",0,data/dev/US20200148885A1.txt,1
4816,"<img> id-US20200148885A1_00044.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4817,"Comparative Synthesis Example 1: Synthesis of Compound 1-X
",1,data/dev/US20200148885A1.txt,0
4819,"The compound thus obtained was confirmed to be a target compound from the following analysis results: MS (ESI) (m/z): 511(+), divalent Elemental analysis values: CHN measurement values (78.13%, 7.48%, 7.78%); theoretical values (78.06%, 7.75%, 7.69%)
",0,data/dev/US20200148885A1.txt,1
4820,"<img> id-US20200148885A1_00045.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4821,"Synthesis Example 18: Synthesis of Compound 2-1
",1,data/dev/US20200148885A1.txt,0
4823,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1270 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.01%, 2.88%, 2.59%); theoretical values (34.29%, 2.91%, 2.64%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4824,"<img> id-US20200148885A1_00046.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4825,"Synthesis Example 19: Synthesis of Compound 2-2
",1,data/dev/US20200148885A1.txt,0
4827,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1326 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.28%, 3.15%, 2.63%); theoretical values (35.18%, 3.11%, 2.59%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4828,"<img> id-US20200148885A1_00047.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4831,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1355 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.55%, 3.24%, 2.61%); theoretical values (35.61%, 3.20%, 2.57%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4832,"<img> id-US20200148885A1_00048.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4835,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1078 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (30.20%, 3.14%, 2.86%); theoretical values (30.070, 3.10%, 2.81%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4836,"<img> id-US20200148885A1_00049.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4837,"Synthesis Example 22: Synthesis of Compound 2-5
",1,data/dev/US20200148885A1.txt,0
4839,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1106 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (30.63%, 3.18%, 2.75%); theoretical values (30.59%, 3.20%, 2.78%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4840,"<img> id-US20200148885A1_00050.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4841,"Synthesis Example 23: Synthesis of Compound 2-6
",1,data/dev/US20200148885A1.txt,0
4843,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1383 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.25%, 3.33%, 2.54%); theoretical values (36.04%, 3.30%, 2.55%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4844,"<img> id-US20200148885A1_00051.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4845,"Synthesis Example 24: Synthesis of Compound 2-7
",1,data/dev/US20200148885A1.txt,0
4847,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1383 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.25%, 3.33%, 2.54%); theoretical values (36.04%, 3.30%, 2.55%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4848,"<img> id-US20200148885A1_00052.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4849,"Synthesis Example 25: Synthesis of Compound 2-8
",1,data/dev/US20200148885A1.txt,0
4851,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1440 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.88%, 3.49%, 2.51%); theoretical values (36.87%, 3.48%, 2.50%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4852,"<img> id-US20200148885A1_00053.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4855,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1352 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (34.88%, 3.79%, 2.58%); theoretical values (34.92%, 3.83%, 2.57%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4856,"<img> id-US20200148885A1_00054.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4857,"Comparative Synthesis Example 2: Synthesis of Compound 2-X
",1,data/dev/US20200148885A1.txt,0
4859,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1122 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (29.04%, 2.90%, 2.81%); theoretical values (29.01%, 2.88%, 2.85%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4864,"(1) Synthesis of Binder Resin A)
",0,data/dev/US20200148885A1.txt,1
4871,"(1) Synthesis of Block Copolymer B
",0,data/dev/US20200148885A1.txt,1
4874,"(2) Production of Phosphorus-Based Block Copolymer Solution
",0,data/dev/US20200148885A1.txt,1
4877,"(1) Synthesis of Phosphate Triester Compound A
",0,data/dev/US20200148885A1.txt,1
4878,"First, 70 parts by mass of chloroform, 20.89 parts by mass of hydroxyethyl acrylate and 12.14 parts by mass of triethylamine were put in a reactor equipped with a cooling tube, an addition funnel, a nitrogen inlet, a mechanical stirrer and a digital thermometer. With stirring the mixed solution under a nitrogen atmosphere, the solution temperature was cooled to about 5° C. by use of an ice bath. Then, a solution obtained by diluting 6.13 parts by mass of phosphoryl chloride with 10 parts by mass of chloroform, was continuously added in a dropwise manner for 15 minutes, while controlling the solution temperature so as not to exceed 30° C. After the dropwise addition was completed, the ice bath was taken out, and the solution was stirred for three hours at room temperature. Then, 30 parts by mass of pure water was added thereto, and the mixed solution was stirred for 30 minutes. Then, the resulting reacted solution was taken out therefrom and washed three times with saturated brine. An organic layer thus formed was dehydrated with magnesium sulfate, filtered, and then mixed with 0.015 g of p-methoxyphenol. Then, the solvent was removed from the mixture, thereby obtaining 14.09 g (yield 90%) of a phosphate triester compound A represented by the following chemical formula (A). The thus-obtained compound had an acid value of 5 mgKOH/g. As a result of 32P-NMR measurement, it was found that the main component of the compound was phosphate triester; a slight amount of phosphoric diester was detected; and the peak integral ratio of the phosphate triester was 90% or more.
",0,data/dev/US20200148885A1.txt,1
4879,"<img> id-US20200148885A1_00056.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4880,"(2) Preparation of Binder Composition B)
",0,data/dev/US20200148885A1.txt,1
4883,"(1) First, 13.0 parts by mass of the color material 2-1 of Synthesis Example 18, 20.80 parts by mass (effective solid content 5.20 parts by mass) of the salt-type block polymer dispersant A solution prepared in Preparation Example 1, 11.82 parts by mass (effective solid content 5.20 parts by mass) of the binder resin A of Preparation Example 2, and 54.38 parts by mass of PGMEA were mixed. Using a paint shaker (manufactured by Asada Iron Works Co., Ltd.), the mixture was subjected to a pre-dispersion for 1 hour with 2 mm zirconia beads and then a main dispersion for 6 hours with 0.1 mm zirconia beads, thereby obtaining a color material dispersion liquid A.
",0,data/dev/US20200148885A1.txt,1
4891,"Example 12: Preparation of Color Resin Composition L
",0,data/dev/US20200148885A1.txt,1
4961,"(1) Formation of Light Shielding Layer
",0,data/dev/US20200148885A1.txt,1
4968,"(2) Formation of Color Layer
",0,data/dev/US20200148885A1.txt,1
5055,"<img> id-US20200031833A1_00022.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5057,"<img> id-US20200031833A1_00023.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5069,"<img> id-US20200031833A1_00027.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5075,"<img> id-US20200031833A1_00029.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5081,"<img> id-US20200031833A1_00031.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5084,"<img> id-US20200031833A1_00032.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5087,"<img> id-US20200031833A1_00033.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5090,"<img> id-US20200031833A1_00034.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5100,"<img> id-US20200031833A1_00035.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5102,"<img> id-US20200031833A1_00036.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5104,"<img> id-US20200031833A1_00037.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5109,"<img> id-US20200031833A1_00038.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5113,"<img> id-US20200031833A1_00039.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5117,"<img> id-US20200031833A1_00040.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5189,"<img> id-US20200031833A1_00041.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5191,"<img> id-US20200031833A1_00042.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5312,"13 & <img> id-US20200031833A1_00055.PNG </img> & 4-(((3-(1,3-dimethyl- 1H-indazol-5-yl)-2,5- dimethylpyrazolo[1,5- a]pyrimidin-7- yl)amino)methyl) benzenesulfonamide
",0,data/dev/US20200031833A1.txt,1
5315,"16 & <img> id-US20200031833A1_00058.PNG </img> & N-(4-(((3-(1,3- dimethyl-1H- indazol-5-yl)-2,5- dimethylpyrazolo [1,5-a]pyrimidin-7- yl)amino)methyl)phenyl) methanesulfonamide
",0,data/dev/US20200031833A1.txt,1
5316,"17 & <img> id-US20200031833A1_00059.PNG </img> & 3-(1,3-dimethyl-1H- indazol-5-yl)-2,5- dimethyl-N-((6- trifluoromethylpyridin- 3-yl)methyl)pyrazolo [1,5-a]pyrimidin-7-amine
",0,data/dev/US20200031833A1.txt,1
5321,"22 & <img> id-US20200031833A1_00064.PNG </img> & 8-(1,3-dimethyl-1H- indazol-5-yl)-2,7- dimethyl-N-((6- methylpyridin-3- yl)methyl)pyrazolo [1,5-a][1,3,5]triazin- 4-amine
",0,data/dev/US20200031833A1.txt,1
5322,"23 & <img> id-US20200031833A1_00065.PNG </img> & 4-(((8-(1,3-dimethyl- 1H-indazol-5-yl)-2,7- dimethylpyrazolo[1,5- a][1,3,5]triazin-4- yl)amino)methyl) benzenesulfonamide
",0,data/dev/US20200031833A1.txt,1
5325,"26 & <img> id-US20200031833A1_00068.PNG </img> & N-(4-(((8-(1,3-dimethyl- 1H-indazol-5-yl)- 2,7-dimethylpyrazolo [1,5-a][1,3,5]triazin-4- yl)amino)methyl)phenyl) methanesulfonamide
",0,data/dev/US20200031833A1.txt,1
5332,"<img> id-US20200031833A1_00071.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5334,"Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole, used in the General Procedures 1-3, was synthesized by the below 2-step procedure illustrated in the following reaction scheme:
",0,data/dev/US20200031833A1.txt,1
5335,"<img> id-US20200031833A1_00072.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5340,"General Procedure 1: Synthesis of Imidazopyridazine Derivatives (Scheme 1)
",0,data/dev/US20200031833A1.txt,1
5341,"<img> id-US20200031833A1_00073.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5366,"1 & 1H-NMR (CDCl3, 400 MHz): δ 8.61 (d, 2H), 7.91 (s, 1H), 7.69 (d, 1H), 7.45 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5369,"2 & 1H-NMR (CDCl3, 400 MHz): δ 8.56 (d, 1H), 8.32 (s, 1H), 8.16 (d, 1H), 7.86 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5373,"3 & 1H-NMR (CDCl3, 400 MHz): δ 7.90 (s, 1H), 7.70 (d, 1H), 7.45 (d, 1H), 7.32 (m, 4 H),
",1,data/dev/US20200031833A1.txt,0
5376,"4 & 1H-NMR (CDCl3, 400 MHz): δ 8.20 (d, 1H), 7.89 (s, 1H), 7.67 (d, 1H), 7.62 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5380,"5 & 1H-NMR (CDCl3, 400 MHz): δ 7.89 (s, 1H), 7.68 (d, 1H), 7.46 (d, 1H), 7.27 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5383,"6 & 1H-NMR (CDCl3, 400 MHz): δ 7.90 (s, 1H), 7.68 (d, 1H), 7.44 (d, 1H), 7.32 (d, 2H),
",1,data/dev/US20200031833A1.txt,0
5386,"7 & 1H-NMR (CDCl3, 400 MHz): δ 8.02 (m, 2H), 7.90 (s, 1H), 7.82 (d, 1H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5390,"General Procedure 2: Synthesis of Pyrazolopyrimidine Derivatives (Scheme 2)
",0,data/dev/US20200031833A1.txt,1
5391,"<img> id-US20200031833A1_00074.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5417,"8 & 1H-NMR (DMSO, 400 MHz): δ 8.52 (m, 3H), 7.85 (s, 1H), 7.75 (d, 1H), 7.59 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5420,"9 & 1H-NMR (DMSO, 400 MHz): δ 8.53 (s, 1H), 8.41 (s, 1H), 7.84 (s, 1H), 7.73 (dd, 2H),
",1,data/dev/US20200031833A1.txt,0
5422," & 3H), 2.43 (s, 3H), 2.34 (s, 3H), LCMS: 412.3 [M + H], HPLC purity: 99.86%
",0,data/dev/US20200031833A1.txt,1
5423,"10 & 1H-NMR (DMSO, 400 MHz): δ 8.38 (t, 1H), 7.84 (s, 1H), 7.75 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5426,"11 & 1H-NMR (DMSO, 400 MHz): δ 8.48 (t, 1H), 7.85 (s, 1H), 7.75 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5429,"12 & 1H-NMR (CDCl3, 400 MHz): δ 8.00 (s, 1H), 7.94 (d, 1H), 7.87 (d, 1H), 7.70 (dd, 2H),
",1,data/dev/US20200031833A1.txt,0
5431," & 3H), 2.58 (s, 3H), 2.45 (s, 3H), LCMS: 475.3 [M + H], HPLC purity: 99.79%
",0,data/dev/US20200031833A1.txt,1
5432,"13 & 1H-NMR (CDCl3, 400 MHz): δ 7.85 (m, 3H), 7.69 (d, 1H), 7.51 (d, 2H), 7.41 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5435,"14 & 1H-NMR (CDCl3, 400 MHz): δ 8.21 (d, 1H), 7.87 (s, 1H), 7.73 (d, 1H), 7.63 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5438,"15 & 1H-NMR (CDCl3, 400 MHz): δ 7.87 (s, 1H), 7.72 (d, 1H), 7.40 (d, 1H), 7.30 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5441,"16 & 1H-NMR (DMSO, 400 MHz): δ 9.71 (s, 1H), 8.41 (t, 1H), 7.85 (s, 1H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5444,"17 & 1H-NMR (DMSO, 400 MHz): δ 8.86 (s, 1H), 8.58 (t, 1H), 8.08 (d, 1H), 7.89 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5446," & 3H), 2.50 (s, 3H), 2.32 (s, 3H), LCMS: 466.6 [M + H], HPLC purity: 99.40%
",0,data/dev/US20200031833A1.txt,1
5447,"18 & 1H-NMR (DMSO, 400 MHz): δ 8.44 (t, 1H), 7.85 (s, 1H), 7.77 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5450,"19 & 1H-NMR (DMSO, 400 MHz): δ 8.44 (t, 1H), 7.82 (s, 1H), 7.71 (d, 1H), 7.54 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5454,"General Procedure 3: Synthesis of Pyrazolo Triazine Derivatives (Scheme 3)
",0,data/dev/US20200031833A1.txt,1
5455,"<img> id-US20200031833A1_00075.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5482,"20 & 1H-NMR (DMSO, 400 MHz): δ 9.28 (s, 1H), 8.52 (d, 2H), 7.84 (s, 1H), 7.71 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5485,"21 & 1H-NMR (DMSO, 400 MHz): δ 9.14 (s, 1H), 8.41 (s, 1H), 7.82 (s, 1H), 7.70 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5488,"22 & 1H-NMR (DMSO, 400 MHz): δ 9.26 (s, 1H), 8.49 (d, 1H), 7.82 (d, 1H), 7.58 (m, 2H),
",1,data/dev/US20200031833A1.txt,0
5491,"23 & 1H-NMR (DMSO, 400 MHz): δ 9.32 (s, 1H), 7.84 (s, 1H), 7.78 (d, 2H), 7.71 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5494,"24 & 1H-NMR (DMSO, 400 MHz): δ 9.26 (t, 1H) 7.83 (s, 1H), 7.69 (d, 1H), 7.61 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5497,"25 & 1H-NMR (DMSO, 400 MHz): δ 9.34 (t, 1H) 8.02 (s, 1H), 7.84 (d, 2H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5500,"26 & 1H-NMR (DMSO, 400 MHz): δ 9.68 (bs, 1H) 9.18 (s, 1H), 7.83 (s, 1H), 7.69 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5503,"27 & 1H-NMR (CDCl3, 400 MHz): δ 7.81 (s, 1H), 7.68 (d, 1H), 7.40 (d, 1H), 7.21 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5506,"28 & 1H-NMR (DMSO, 400 MHz): δ 9.19 (s, 1H), 8.18 (t, 1H), 7.82 (s, 1H), 7.78 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5526," & 3, 11, 24 & (4-chlorophenyl)methanamine
",0,data/dev/US20200031833A1.txt,1
5532," & 16, 26 & N-(4-(aminomethyl)phenyl)methanesulfonamide
",0,data/dev/US20200031833A1.txt,1
5534," & 18 & benzylamine
",0,data/dev/US20200031833A1.txt,1
5535," & 19 & (4-fluorophenyl)methanamine
",0,data/dev/US20200031833A1.txt,1
5757,"Nuclear magnetic resonance (1HNMR) spectra were obtained on 600 MHz Bruker Advance DPX600 spectrometer at Faculty of Science, King Abdulaziz University using Me4Si as the internal reference, and DMSO-d6 or CDCl3 were used as solvents. The chemical shifts were measured in δ ppm. General procedure for the synthesis of target compounds.
",1,data/dev/US10654800B1.txt,0
5762,"N.B. All compounds were confirmed with LC/MS and showed excellent purities (over 95%) 1H NMR of GLP-1: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46 (brs, 6H, 2CH2, 2 CH), 1.50-1.51 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.33 (br, 1H, NH—CH2), 3.24 (brs, 2H, CH2), 4.45 (brs, 1H, OH), 7.04-7.07 (t, 1H, Arom-H), 7.29-7.33 (t, 2H, Arom-H) 7.60-7.63 (d, 2H, Arom-H), 9.88 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5763,"1H NMR of GLP-2: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.51 (brs, 4H, 2CH2), 2.14 (brs, 2H, CH2), 2.26 (s, 3H, CH3), 2.75 (br, 1H, NH—CH2), 3.23 (brs, 2H, CH2), 4.46 (brs, 1H, OH), 6.99-7.03 (t, 1H, Arom-H), 7.16-7.18 (d, 1H, Arom-H) 7.20-7.23 (t, 1H, Arom-H), 8.01-8.03 (d, 1H, Arom-H), 9.86 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5764,"1H NMR of GLP-3: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46-1.47 (brs, 6H, 2CH2+2 CH), 1.51-1.51 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.25 (s, 3H, CH3), 2.30 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 4.41 (brs, 1H, OH), 7.10-7.12 (d, 2H, Arom-H), 7.49-7.51 (d, 2H, Arom-H), 9.74 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5765,"1H NMR of GLP-5: DMSO-d6, δ 1.42 (brs, 2H, CH2), 1.46 (brs, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.78 (br, t, 1H, NH—CH2), 3.33 (brs, 2H, CH2), 3.88 (s, 3H, OCH3), 4.45 (brs, 1H, OH), 6.90-6.93 (m, 1H, Arom-H), 7.00-7.07 (m, 1H, Arom-H) 8.24-8.25 (d, 1H, Arom-H), 10.27 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5766,"1H NMR of GLP-14: DMSO-d6, δ 1.44 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.52 (brs, 4H, 2CH2), 2.16 (brs, 2H, CH2), 2.56 (br, 1H, NH—CH2), 3.27 (brs, 2H, CH2), 4.54 (brs, 1H, OH), 7.31-7.33 (t, 1H, Arom-H), 7.70-7.72 (t, 1H, Arom-H) 7.75-7.76 (d, 1H, Arom-H), 8.51-8.53 (d, 1H, Arom-H), 10.5 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5767,"1H NMR of GLP-15: DMSO-d6, δ 1.45 (brs, 2H, CH2), 1.49 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.16 (brs, 2H, CH2), 2.57 (br, 1H, NH—CH2), 3.31 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 7.44-7.45 (d, 1H, Arom-H), 7.59-7.61 (t, 1H, Arom-H) 7.89-7.91 (d, 1H, Arom-H), 8.20 (s, 1H, Arom-H), 10.2 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5768,"1H NMR of GLP-16: DMSO-d6, δ 1.44 (brs, 2H, CH2), 1.51 (brs, 6H, 2CH2, 2 CH), 1.54 (brs, 4H, 2CH2), 2.15 (brs, 2H, CH2), 2.69-2.71 (br, 1H, NH—CH2), 3.28 (brs, 2H, CH2), 3.45 (s, 3H, OCH3), 4.50 (brs, 1H, OH), 7.18-7.21 (d, 1H, Arom-H), 7.63-7.65 (t, 1H, Arom-H) 7.99-8.01 (d, 1H, Arom-H), 8.58-8.59 (d, 1H, Arom-H), 12.11 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5769,"1H NMR of GLP-17: DMSO-d6, δ 1.45 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.15 (brs, 2H, CH2), 2.36 (br, 1H, NH—CH2), 3.24 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 6.47-6.50 (dd, 1H, Arom-H), 6.96-6.97 (d, 1H, Arom-H) 7.09-7.12 (d, 1H, Arom-H), 7.25 (s, 1H, Arom-H), 9.46 (brs, 1H, OH), 9.76 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5770,"1H NMR of GLP-19: CDCl3, δ 1.52-1.53 (br, t, 2H, CH2), 1.62-1.63 (br, d, 6H, 2CH2, 2 CH), 1.67 (brs, 4H, 2CH2), 1.74 (brs, 1H, NH—CH2), 2.29 (brs, 2H, CH2), 3.42 (brs, 2H, CH2), 4.62 (brs, 1H, OH), 7.13-7.16 (m, 1H, Arom-H), 7.57-7.60 (m, 2H, Arom-H) 8.54-8.56 (br, d, 1H, Arom-H), 10.64 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5771,"1H NMR of GLP-26: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.62 (br, 1H, NH—CH2), 3.30 (brs, 2H, CH2), 4.49 (brs, 1H, OH), 7.54-7.55 (m, 1H, Arom-H), 7.94-7.96 (dt, 1H, Arom-H) 8.17-8.18 (br, 1H, Arom-H), 10.18 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5772,"1H NMR of GLP-27: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.45-1.46 (br, d, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.14 (brs, 2H, CH2), 2.62-2.63 (br, t, 1H, NH—CH2), 3.26 (brs, 2H, CH2), 4.50 (brs, 1H, OH), 7.10-7.14 (m, 1H, Arom-H), 7.18-7.20 (t, 1H, Arom-H) 7.29-7.32 (m, 1H, Arom-H), 8.20-8.22 (t, 1H, Arom-H), 10.09 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5773,"1H NMR of GLP-30: DMSO-d6, δ 1.46 (brs, 2H, CH2), 1.52 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.17 (brs, 2H, CH2), 2.31 (s, 3H, CH3), 2.75 (br, 1H, NH—CH2), 3.23 (brs, 2H, CH2), 4.55 (brs, 1H, OH), 6.99-7.03 (t, 1H, Arom-H), 7.16-7.18 (d, 1H, Arom-H) 7.20-7.23 (t, 1H, Arom-H), 8.01-8.03 (d, 1H, Arom-H), 9.86 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5774,"1H NMR of GLP-31: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46-1.47 (br, d, 6H, 2CH2, 2 CH), 1.50-1.51 (br, d, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.62-2.63 (br, t, 1H, NH—CH2), 3.26 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 6.88-6.91 (m, 1H, Arom-H), 7.33-7.39 (m, 2H, Arom-H) 7.66-7.67 (m, 1H, Arom-H), 10.05 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5775,"1H NMR of GLP-43: CDCl3, δ 1.49 (brs, 2H, CH2), 1.55 (brs, 6H, 2CH2, 2 CH), 1.60 (brs, 4H, 2CH2), 2.22 (br, 1H, NH—CH2), 2.28 (brs, 2H, CH2), 3.36 (brs, 2H, CH2), 4.81 (brs, 1H, OH), 7.28-7.29 (d, 2H, Arom-H), 7.53-7.54 (d, 2H, Arom-H) 10.53 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5776,"1H NMR of GLP-53: CDCl3, δ 1.52 (br, t, 2H, CH2), 1.62-1.63 (br, d, 6H, 2CH2, 2 CH), 1.66 (brs, 4H, 2CH2), 2.23 (brs, 1H, NH—CH2), 2.27 (brs, 2H, CH2), 3.43 (brs, 2H, CH2), 4.42-4.46 (d, 2H, N—CH 2 -Ph), 7.26-7.29 (m, 3H, Arom-H), 7.32-7.35 (m, 2H, Arom-H) 7.79 (br, t, 1H, —CO—NH—CH2).
",1,data/dev/US10654800B1.txt,0
5777,"1H NMR of GLP-54: CDCl3, δ 1.49 (br, t, 2H, CH2), 1.54 (br, d, 6H, 2CH2, 2 CH), 1.67 (brs, 4H, 2CH2), 2.23 (brs, 1H, NH—CH2), 2.27 (brs, 2H, CH2), 3.41 (brs, 2H, CH2), 4.42-4.46 (d, 2H, N—CH 2 -Ph), 7.00-7.03 (d, 2H, Arom-H), 7.25-7.27 (d, 2H, Arom-H) 7.74 (br, t, 1H, —CO—NH—CH2).
",1,data/dev/US10654800B1.txt,0
5778,"1H NMR of GLP-59: CDCl3, δ 1.37 (brs, 2H, CH2), 1.43 (br, 3H, CH+CH2) 1.47-1.50 (br, m, 1H, CH2), 1.56-1.58 (br, m, 2H, CH2), 1.62-1.64 (br, m, 2H, CH2), 2.03 (brs, 1H, NH—CH2), 2.21 (brs, 2H, CH2), 2.83-2.85 (t, 2H, CH 2 Ph), 3.2 (d, 2H, N—CH 2—CH 2), 3.53-3.56, (q, 2H, N—CH 2 —CH2), 7.21-7.25 (m, 3H, Arom-H), 7.30-7.33 (m, 2H, Arom-H), 7.59 (br, t, 1H, CO—NH).
",1,data/dev/US10654800B1.txt,0
5779,"1H NMR of GLP-60: CDCl3, δ 1.45 (brs, 2H, CH2), 1.49 (brs, 6H, 2CH2, 2 CH), 1.56 (brs, 4H, 2CH2), 2.05 (brs, 2H, CH2), 2.29 (br, 1H, NH—CH2), 3.35 (s, 2H, CH2), 4.58 (brs, 1H, OH), 6.80-6.83 (m, 2H, Arom-H), 7.40-7.43 (d, 2H, Arom-H), 9.34 (brs, 1H, OH), 9.44 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5780,"1H NMR of GLP-73: DMSO-d6, δ 0.85-0.88 (t, 1H, NH—CH2), 1.25 (brs, 1H, CH2), 1.42 (brs, 2H, CH2), 1.48 (brs, 9H, 4CH2+CH), 2.14 (brs, 2H, CH2), 3.4 (brs, 1H, OH), 3.44 (s, 2H, CH2), 7.46 (s, 1H, Arom-H).
",1,data/dev/US10654800B1.txt,0
5781,"1H NMR of GLP-107: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.47 (brs, 6H, 2CH2, 2 CH), 1.52 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.34 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 4.50 (brs, 1H, OH), 6.46-6.49 (dd, 1H, Arom-H), 6.94-6.95 (d, 1H, Arom-H) 7.07-7.10 (d, 1H, Arom-H), 7.24 (s, 1H, Arom-H), 9.43 (brs, 1H, OH), 9.72 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5782,"1H NMR of GLP-110: DMSO-d6, δ 1.57-1.59 (br, d, 3H, 3CH), 1.66-1.68 (br, d, 3H, 3CH), 1.90 (brs, 6H, 3CH2), 2.13 (br, 1H, 3CH), 4.02-4.04 (t, 2H, CH2), 7.59-7.60 (m, 2H, Arom-H), 7.92-7.94 (m, 1H, Arom-H), 8.12-8.13 (d, 1H, Arom-H) 9.11 (br, s, 1H, NH), 11.62 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5783,"1H NMR of GLP-111: DMSO-d6, δ 1.56-1.57 (br, m, 9H, 3CH2), 1.61-1.63 (br, m, 2H, CH2), 2.01 (brs, 4H, CH2), 2.36 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 5.77 (s, 1H, OH), 6.44-6.46 (dd, 1H, Arom-H), 6.92-6.93 (dd, 1H, Arom-H) 7.06-7.09 (t, 1H, Arom-H), 7.21-7.22 (t, 1H, Arom-H), 9.40 (br, s, 1H, NH), 9.74 (br, s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5784,"1H NMR of GLP-112: DMSO-d6, δ 1.56-1.58 (br, d, 3H, 3CH), 1.65-1.67 (br, d, 3H, 3CH), 1.90 (brs, 6H, 3CH2), 2.12 (br, 1H, 3CH), 3.99 (br, 2H, CH2), 6.40-6.443 (dt, 1H, Arom-H), 7.70-7.72 (dt, 1H, Arom-H), 9.11 (br, s, 1H, NH), 11.37 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5785,"1H NMR of GLP-117: DMSO-d6, δ 1.59-1.80 (br, m, 12H, 6CH2), 2.01 (br, s, 3H, 3CH), 3.31 (br, s, 2H, CH2), 4.63 (br, s, 1H, NH), 7.47-7.48 (d, 1H, Arom-H), 8.15-8.20 (dd, 1H, Arom-H) 8.67-8.68 (d, 1H, Arom-H), 11.08 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5786,"1H NMR of GLP-118: DMSO-d6, δ 1.58-1.69 (m, 3H, 3CH2), 1.89 (br, s, 6H, 3 CH2), 2.01 (s, 3H, 3CH), 4.01-4.03 (t, 1H, NH), 4.64 (br, s, 1H, CH2), 7.66-7.68 (dd, 1H, Arom-H), 7.84-7.85 (d, 2H, Arom-H), 7.92-7.94 (dd, 1H, Arom-H) 9.04 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5787,"1H NMR of GLP-119: DMSO-d6, δ 1.53-1.62 (m, 12H, 6 CH2), 2.01 (br, s, 3H, 3CH), 3.28 (br, s, 2H, CH2), 3.39 (br, s, 1H, NH), 7.10-7.13 (m, 1H, Arom-H), 7.78-7.81 (m, 1H, Arom-H) 8.10-8.11 (d, 1H, Arom-H), 8.31-8.32 (m, 1H, Arom-H), 10.18 (s, 1H, NH—CO).
",1,data/dev/US10654800B1.txt,0
5788,"1H NMR of GLP-120: DMSO-d6, δ 1.55-1.64 (m, 12H, 6CH2), 2.03 (br, s, 3H, 3CH), 2.13 (s, 6H, 2CH3), 3.27 (br, s, 2H, CH2), 3.38 (br, s, 1H, NH), 7.10 (s, 3H, Arom-H), 9.31 (s, 1H, NH—CO).
",1,data/dev/US10654800B1.txt,0
5837,"60 & p-OHPh & H & OH & 20.11* & 7.54 & N/A
",0,data/dev/US10654800B1.txt,1
6054,"I-2 & F & H & adenine
",0,data/dev/US20180092937A1.txt,1
6055,"I-3 & F & H & purine
",0,data/dev/US20180092937A1.txt,1
6056,"I-4 & F & H & guanine
",0,data/dev/US20180092937A1.txt,1
6057,"I-5 & F & H & xanthine
",0,data/dev/US20180092937A1.txt,1
6058,"I-6 & F & H & hypoxanthine
",0,data/dev/US20180092937A1.txt,1
6059,"I-7 & OH & H & adenine
",0,data/dev/US20180092937A1.txt,1
6060,"I-8 & OH & H & purine
",0,data/dev/US20180092937A1.txt,1
6061,"I-9 & OH & H & guanine
",0,data/dev/US20180092937A1.txt,1
6062,"I-10 & OH & H & xanthine
",0,data/dev/US20180092937A1.txt,1
6063,"I-11 & OH & H & hypoxanthine
",0,data/dev/US20180092937A1.txt,1
6316,"ACN acetonitrileaq. aqueous° C. degree CelsiusDA diode arrayDBU diazabicyclo[5.4.0]undec-7-eneCEP (2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramiditeDCM dichloromethaneDDTT 3-((N,N-dimethyl-aminomethylidene)amino)-3H-1,2,4-dithiazole-3-thioneDIPEA diisopropylethylamineDMAP 4-dimethylaminopyridineDMF N,N-dimethylformamideDMOCP 2-chloro-5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinaneDMT 4,4'-dimethoxytritylESI-MS electrospray ionisation mass spectrometryEtOAc ethyl acetateeq equivalentFC flash-chromatography, SiO2 is used if no further details givenh hourHCl hydrogenchlorideHATU [dimethylamino-(1,2,3-triazolo[4,5-b]pyridin-3-yloxy)-methylene]-dimethyl-ammonium hexafluorophosphateHPLC high performance liquid chromatographyL literLiHMDS lithium Hexamethyldisilazidem/z mass-to-charge ratioMeOH methanolmin minutemL milliliterMS mass spectrumn.d. not determinedNH4OH solution of NH3 in waterPd-PEPPSI-IPent™ dichloro[1,3-bis(2,6-Di-3-pentylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II)psi pound per square inchRT room temperature (about 20° C.)SEM 2-(trimethylsilyl)ethoxymethylSol solventTBS tert-butyl-dimethylsilylTEA triethyl amineTEAF triethylammonium formateTF/TFA trifluoroacetic acidTFAA trifluoroacetic acid anhydrideTHF tetrahydrofurantR retention time in minutes
",0,data/dev/US20180092937A1.txt,1
6441,"Intermediate 1.1
",1,data/dev/US20180092937A1.txt,0
6442,"Imidazopyridazinon-β-D-ribofuranoside (1-(β-D-ribofuranosyl)imidazo[4,5-d]pyridazin-4(5H)-one)
",1,data/dev/US20180092937A1.txt,0
6443,"<img> id-US20180092937A1-20180405-C00015.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6445,"Intermediate 1.2
",1,data/dev/US20180092937A1.txt,0
6446,"5'-DMT-imidazopyridazinon-β-D-ribofuranoside
",1,data/dev/US20180092937A1.txt,0
6447,"<img> id-US20180092937A1-20180405-C00016.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6451,"Intermediate 1.3-a and Intermediate 1.3-b
",1,data/dev/US20180092937A1.txt,0
6452,"5'-DMT-2'-TBS-imidazopyridazinon-β-D-ribofuranoside (Intermediate 1.3-a) and 5'-DMT-3'-TBS-imidazopyridazinon-β-D-ribofuranoside (Intermediate 1.3-b)
",1,data/dev/US20180092937A1.txt,0
6453,"<img> id-US20180092937A1-20180405-C00017.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6458,"Intermediate 1.4
",1,data/dev/US20180092937A1.txt,0
6459,"5'-DMT-3'-TBS-2'-CEP-imidazopyridazinon-β-D-ribofuranoside
",1,data/dev/US20180092937A1.txt,0
6460,"<img> id-US20180092937A1-20180405-C00018.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6465,"Intermediate 1.5
",1,data/dev/US20180092937A1.txt,0
6467,"<img> id-US20180092937A1-20180405-C00019.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6472,"The flask was stoppered, carefully sealed and stored at +2° C. for 16 hours. The solvents were evaporated under reduced pressure and the residue was azeotroped with anhydrous acetonitrile (4×15 mL). During the last evaporation procedure the solution was concentrated to approximately 5 mL of final azeotrope. The resulting anhydrous solution of intermediate 1.5 was immediately used in the next sequence of reactions.
",0,data/dev/US20180092937A1.txt,1
6473,"Intermediate 1.6
",1,data/dev/US20180092937A1.txt,0
6474,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-3'-H-phosphonate-N6-Bz-adenosine
",1,data/dev/US20180092937A1.txt,0
6480,"The flask was stoppered, carefully sealed and stored at +2° C. for 16 hours. The mixture was evaporated under reduced pressure and the residue was co-evaporated with anhydrous pyridine (2×20 mL) under reduced pressure. A further portion of 40 mL anhydrous pyridine was added and the residue was concentrated under reduced pressure to approximately 20 mL total volume. The resulting anhydrous solution of INTERMEDIATE 1.6 was immediately used in the next sequence of reactions.
",0,data/dev/US20180092937A1.txt,1
6481,"Intermediate 1.7
",1,data/dev/US20180092937A1.txt,0
6482,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-N6-Bz-adenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6489,"Intermediate 1.8
",1,data/dev/US20180092937A1.txt,0
6490,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-TBS-adenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6497,"Intermediate 2.1
",1,data/dev/US20180092937A1.txt,0
6501,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 2.1.
",1,data/dev/US20180092937A1.txt,0
6504,"Intermediate 2.2
",1,data/dev/US20180092937A1.txt,0
6505,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-F-3'-H-phosphonate-N6-Bz-2'-deoxyadenosine
",1,data/dev/US20180092937A1.txt,0
6508,"Intermediate 2.3
",1,data/dev/US20180092937A1.txt,0
6509,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-F-N6-Bz-2'-deoxyadenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6517,"Intermediate 2.4
",1,data/dev/US20180092937A1.txt,0
6518,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-F-2'-deoxyadenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6521,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 2.4-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6526,"Intermediate 3.1
",1,data/dev/US20180092937A1.txt,0
6530,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 3.1.
",1,data/dev/US20180092937A1.txt,0
6533,"Intermediate 3.2
",1,data/dev/US20180092937A1.txt,0
6534,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-3'-H-phosphonate-N6-Bz-LNA-adenine
",1,data/dev/US20180092937A1.txt,0
6537,"Intermediate 3.3
",1,data/dev/US20180092937A1.txt,0
6538,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphoro-thioate-N6-Bz-LNA-adenine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6541,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 3.3-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6546,"Intermediate 3.4
",1,data/dev/US20180092937A1.txt,0
6547,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-LNA-adenine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6550,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 3.4-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6555,"Intermediate 4.1
",1,data/dev/US20180092937A1.txt,0
6556,"5'-OH-2'-TBS-3'-H-phosphonate-purine-β-D-ribofuranoside
",1,data/dev/US20180092937A1.txt,0
6559,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 4.1.
",1,data/dev/US20180092937A1.txt,0
6562,"Intermediate 4.2
",1,data/dev/US20180092937A1.txt,0
6563,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-3'-H-phosphonate-purine-β-D-ribofuranoside
",1,data/dev/US20180092937A1.txt,0
6566,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 4.2 as a mixture of diastereoisomers.
",1,data/dev/US20180092937A1.txt,0
6570,"Intermediate 4.3
",1,data/dev/US20180092937A1.txt,0
6571,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphoro-thioate-2'-TBS-purine-β-D-ribofuranoside-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6578,"Intermediate 4.4
",1,data/dev/US20180092937A1.txt,0
6579,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-TBS-purine-β-D-ribofuranoside-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6592,"Example 1.1 and Example 1.2
",1,data/dev/US20180092937A1.txt,0
6593,"Cyclic (imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-adenosine-(3'→5')-phosphorothioate)
",1,data/dev/US20180092937A1.txt,0
6599,"Desalting of EXAMPLE 1.1, TEA-salt was performed by preparative reversed phase medium pressure liquid chromatography (MPLC). The product solution (˜40 mL) was applied to a Merck LiChroprep®RP-18 column (15-25 μm; 450×25 mm; ˜220 mL), previously equilibrated with water. The column was washed with water to remove excess TEAF buffer. Afterwards, 2% 2-propanol in water was used to elute the desalted EXAMPLE 1.1. Product-containing fractions were partially concentrated under reduced pressure and subsequently applied to a SP Sepharose™ Fast Flow cation exchange column (45-165 μm; 125×35 mm; 120 mL) Na+-form, previously regenerated with 2 M sodium chloride and washed with water. The column was washed with water until no UV-absorbance was detectable anymore (detection wavelength 254 nm). Product-containing fractions were carefully evaporated under reduced pressure and additionally dried in vacuo to yield EXAMPLE 1.1 as disodium salt.
",1,data/dev/US20180092937A1.txt,0
6605,"Desalting and salt change from TEA to sodium of EXAMPLE 1.2, TEA salt was performed in similar fashion as described for EXAMPLE 1.1, TEA salt.
",1,data/dev/US20180092937A1.txt,0
6610,"Example 2.1 and Example 2.2
",1,data/dev/US20180092937A1.txt,0
6611,"Cyclic (imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-F-2'-deoxyadenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6619,"Example 2.2
",1,data/dev/US20180092937A1.txt,0
6625,"Example 3.1 and Example 3.2
",1,data/dev/US20180092937A1.txt,0
6626,"Cyclic (imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-LNA-adenine-(3'→5')-phosphorothioate), Sodium Salt
",1,data/dev/US20180092937A1.txt,0
6628,"EXAMPLES 3.1 and 3.2 were prepared analogously to EXAMPLE 2.1 and 2.2 by using INTERMEDIATE 3.4-d (for EXAMPLE 3-1) and 3.4-c (for EXAMPLE 3-2) as starting material, respectively.
",1,data/dev/US20180092937A1.txt,0
6637,"Example 4.1 and Example 4.2
",1,data/dev/US20180092937A1.txt,0
6638,"Cyclic (imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-purine-β-D ribofuranoside-(3'→5')-phosphorothioate), Sodium Salt
",1,data/dev/US20180092937A1.txt,0
6715,"<img> id-EP3674305A1_00021.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6716,"Compound 1
",1,data/dev/EP3674305A1.txt,0
6719,"Compound 2
",1,data/dev/EP3674305A1.txt,0
6722,"Compound 3
",1,data/dev/EP3674305A1.txt,0
6725,"1H NMR (400 MHz, CDCl3): a (ppm) = 9.66 (br s, 1H), 9.17 (br s, 1H), 9.00 (br s, 2H), 7.73-7.85 (m, 15H), 3.74-3.79 (m, 2H), 3.63-3.67 (m, 2H), 3.38 (br s, 2H), 2.96 (br s, 2H), 2.49 (br s, 1H), 2.28 (br s, 2H), 2.06 (br s, 2H).
",1,data/dev/EP3674305A1.txt,0
6730,"1-2. Synthesis of MitoFreSH-Piperazine (Formula IV)
",0,data/dev/EP3674305A1.txt,1
6731,"<img> id-EP3674305A1_00026.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6732,"Compound 4
",1,data/dev/EP3674305A1.txt,0
6735,"Compound 5
",1,data/dev/EP3674305A1.txt,0
6741,"MitoFreSH-Piperazine (Formula IV)
",1,data/dev/EP3674305A1.txt,0
6745,"<img> id-EP3674305A1_00031.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6752,"Compound 10
",1,data/dev/EP3674305A1.txt,0
6756,"MitoFreSH-Cl (Formula V)
",1,data/dev/EP3674305A1.txt,0
6771,"<img> id-EP3674305A1_00033.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6773,"<img> id-EP3674305A1_00034.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6775,"<img> id-EP3674305A1_00035.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6776,"Compound 2
",1,data/dev/EP3674305A1.txt,0
6779,"Compound 2A 1H NMR (500 MHz, CDCl3): a (ppm) = 6.73 (br, 1H), 4.96 (br, 1H), 3.57-3.69 (m, 8H), 3.51 (m, 2H), 3.41 (s, 2H), 3.34 (m, 2H), 1.45 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6780,"Compound 2B 1H NMR (500 MHz, DMSO-d6): a (ppm) = 8.19 (t, J = 5.2 Hz, 1H), 6.79 (t, J = 5.6 Hz, 1H), 3.59 (s, 2H), 3.04 (m, 2H), 2.88 (m, 2H), 1.37 (s, 9H), 1.33-1.39 (m, 4H), 1.22-1.24 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6781,"Compound 2C 1H NMR (500 MHz, CDCl3): a (ppm) = 7.18 (br, 1H), 4.90(br, 1H), 3.62-3.69 (m, 8H), 3.60 (m, 2H), 3.53 (t, J = 6.0 Hz, 2H), 3.45 (m, 2H), 3.37 (s, 2H), 3.22 (m, 2H), 1.82 (m, 2H), 1.76 (m, 2H), 1.44 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6782,"Compound 3
",1,data/dev/EP3674305A1.txt,0
6785,"Compound 3A 1H NMR (500 MHz, CDCl3): a (ppm) = 8.62 (s, 1H), 8.55 (s, 1H), 7.00 (s, 1H), 6.67 (br, 1H), 5.08 (br, 1H), 3.62-3.65 (m, 5H), 3.57 (t, J = 5.2 Hz, 2H), 3.34-3.39 (m, 6H), 2.87 (t, J = 6.5 Hz, 2H), 2.76 (t, J = 6.2 Hz, 2H), 1.96-2.00 (m, 4H), 1.44 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6786,"Compound 3B 1H NMR (500 MHz, CDCl3): a (ppm) = 8.60 (s, 1H), 8.56 (s, 1H), 7.00 (s, 1H), 6.22 (br, 1H), 4.53 (br, 1H), 3.35-3.40 (m, 6H), 3.11 (m, 2H), 2.87 (t, J = 6.2 Hz, 2H), 2.76 (t, J = 6.1 Hz, 2H), 1.96-2.00 (m, 4H), 1.44 (s, 9H), 1.44-1.50 (m, 4H), 1.35-1.38 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6787,"Compound 3C 1H NMR (500 MHz, CDCl3): a (ppm) = 8.60 (s, 1H), 8.53 (s, 1H), 6.99 (s, 1H), 6.97 (br, 1H), 5.01 (br, 1H), 3.72 (m, 2H), 3.63-3.67(m, 6H), 3.59 (m, 2H), 3.52-3.56 (m, 4H), 3.35-3.39 (m, 4H), 3.22 (m, 2H), 2.87 (t, J = 6.4 Hz, 2H), 2.76 (t, J = 6.2 Hz, 2H), 1.96-2.00 (m, 4H), 1.88 (m, 2H), 1.75 (m, 2H), 1.43 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6788,"GogiFreSH
",1,data/dev/EP3674305A1.txt,0
6791,"GolgiFreSH-A (formula VII) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.52 (s, 1H), 8.49 (s, 1H), 7.64 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 2.3 Hz, 1H), 6.89 (s, 1H), 6.80 (d, J = 9.1 Hz, 1H), 6.61-6.63 (m, 2H), 6.39 (t, J = 5.6 Hz, 1H), 3.80 (s, 3H), 3.65 (s, 2H), 3.48-3.55 (m, 10H), 3.44 (m, 2H), 3.35-3.39 (m, 4H), 2.86 (t, J = 6.2 Hz, 2H), 2.72 (t, J = 6.5 Hz, 2H), 2.40 (s, 3H), 1.95-1.99 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6792,"GolgiFreSH-B (formula VIII) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.57 (s, 1H), 8.50 (s, 1H), 7.66 (m, 2H), 7.48 (m, 2H), 6.98 (s, 1H), 6.90 (d, J = 2.4 Hz, 1H), 6.87 (d, J = 9.1 Hz, 1H), 6.69 (dd, 3J = 9.1 Hz, 4J = 2.4 Hz, 1 H), 6.23 (t, J = 5.7 Hz, 1H), 5.78 (t, J = 5.8 Hz, 1H), 3.82 (s, 3H), 3.65 (s, 2H), 3.28-3.39 (m, 6H), 3.20 (m, 2H), 2.86 (t, J = 6.4 Hz, 2H), 2.76 (t, J = 6.2 Hz, 2H), 2.39 (s, 3H), 1.95-2.00 (m, 4H), 1.50 (m, 2H), 1.42 (m, 2H), 1.22-1.31 (m, 4H); HRMS (m/z): [M+Na]+ 769.2772.
",1,data/dev/EP3674305A1.txt,0
6793,"GolgiFreSH-C (formula IX) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.55 (s, 1H), 8.48 (s, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 8.0 Hz, 2H), 6.98 (t, J = 4.9 Hz, 1H), 6.96 (s, 1H), 6.92 (s, 1H), 6.87 (d, J = 9.0 Hz, 1H), 6.66 (d, J = 9.0 Hz, 1H), 6.34 (t, J = 4.9 Hz, 1H), 3.81 (s, 3H), 3.57-3.63 (m, 8H), 3.42-3.51 (m, 8H), 3.31-3.38 (m, 6H), 2.85 (t, J = 6.2 Hz, 2H), 2.75 (t,J = 5.9 Hz, 2H), 2.37 (s, 3H), 1.95-1.99 (m, 4H), 1.84 (m, 2H), 1.71 (m, 2H); HRMS (m/z): [M+Na]+ 900.3390.
",1,data/dev/EP3674305A1.txt,0
6949,"<img> id-US20180083209A1-20180322-C00021.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6982,"2. Synthesis of Compound 3
",1,data/dev/US20180083209A1.txt,0
6991,"Compound F was synthesized according to the same method of synthesizing Compound B except for using Compound E instead of Compound A in the synthetic method of Compound B. The molecular weight of Compound F measured by FAB-MS was 485.
",1,data/dev/US20180083209A1.txt,0
6994,"Compound 4 was synthesized according to the same method of synthesizing Compound 1 except for using Compounds F and G instead of Compounds B and C in the synthetic method of Compound 1. The molecular weight of Compound 4 measured by FAB-MS was 895.
",1,data/dev/US20180083209A1.txt,0
6995,"4. Synthesis of Compound 6
",0,data/dev/US20180083209A1.txt,1
7008,"<img> id-US20180083209A1-20180322-C00032.TIF </img>
",0,data/dev/US20180083209A1.txt,1
7128,"<img> id-US10815179B1_00011.PNG </img>
",1,data/dev/US10815179B1.txt,0
7131,"<img> id-US10815179B1_00012.PNG </img>
",1,data/dev/US10815179B1.txt,0
7134,"<img> id-US10815179B1_00013.PNG </img>
",1,data/dev/US10815179B1.txt,0
7137,"<img> id-US10815179B1_00014.PNG </img>
",1,data/dev/US10815179B1.txt,0
7140,"<img> id-US10815179B1_00015.PNG </img>
",1,data/dev/US10815179B1.txt,0
7143,"<img> id-US10815179B1_00016.PNG </img>
",1,data/dev/US10815179B1.txt,0
7146,"<img> id-US10815179B1_00017.PNG </img>
",1,data/dev/US10815179B1.txt,0
7149,"<img> id-US10815179B1_00018.PNG </img>
",1,data/dev/US10815179B1.txt,0
7152,"<img> id-US10815179B1_00019.PNG </img>
",1,data/dev/US10815179B1.txt,0
7155,"<img> id-US10815179B1_00020.PNG </img>
",1,data/dev/US10815179B1.txt,0
7158,"<img> id-US10815179B1_00021.PNG </img>
",1,data/dev/US10815179B1.txt,0
7161,"<img> id-US10815179B1_00022.PNG </img>
",1,data/dev/US10815179B1.txt,0
7164,"<img> id-US10815179B1_00023.PNG </img>
",1,data/dev/US10815179B1.txt,0
7167,"<img> id-US10815179B1_00024.PNG </img>
",1,data/dev/US10815179B1.txt,0
7170,"<img> id-US10815179B1_00025.PNG </img>
",1,data/dev/US10815179B1.txt,0
7173,"<img> id-US10815179B1_00026.PNG </img>
",1,data/dev/US10815179B1.txt,0
7397,"(1) Inhalations
",0,data/dev/EP3312182A1.txt,1
7443,"LC-MS/ELSD was performed under the following condition:[column: Waters ACQUITY C18 (particle size: 1.7 × 10-6 m; column length: 30 × 2.1 mm I.D.); flow rate: 1.0 mL/min; column temperature: 40°C; mobile phase (A): 0.1% formic acid aqueous solution; mobile phase (B): 0.1% formic acid-acetonitrile solution; gradient (the ratio of mobile phase (A) : mobile phase (B) is described): [0 min] 95 : 5; [0.1 min] 95 : 5; [1.2 min] 5 : 95; [1.4 min] 5 : 95; [1.41 min] 95 : 5; [1.5 min] 95 : 5; Detector: UV(PDA), ELSD, MS].
",0,data/dev/EP3312182A1.txt,1
7445,"Reference Example 1: N-(1,3-dimethyl-1H-pyrazol-4-yl)formamide
",1,data/dev/EP3312182A1.txt,0
7447,"Reference Example 2: 4,6-Dichloro-3-iodo-1H-pyrazolo[3,4-d]pyrimidine
",1,data/dev/EP3312182A1.txt,0
7457,"Reference Example 7: 3-Iodo-6-(methylsulfonyl)-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
",1,data/dev/EP3312182A1.txt,0
7463,"Example 1: N6-(1,3-dimethyl-1H-pyrazol-4-yl)-3-(1H-indol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
",1,data/dev/EP3312182A1.txt,0
7475,"Example 3: 3-(2,3-Dihydro-1-benzofuran-5-yl)-N6-(1,3-dimethyl-1H-pyrazol-4-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
",1,data/dev/EP3312182A1.txt,0
7481,"A similar procedure to Reference Example 9 → Example 2 was carried out by using the compound prepared in Reference Example 13 instead of the compound prepared in Reference Example 8, and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.
",0,data/dev/EP3312182A1.txt,1
7551,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 → Example 2 was carried out by using 1,3-dimethylpyrazol-4-amine hydrochloride or a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties. Meanwhile, in Example 13-7, HPLC preparative purification was performed instead of silica gel column chromatography in Example 2.
",0,data/dev/EP3312182A1.txt,1
7585,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 was carried out by using 1,3-dimethylpyrazol-4-amine hydrochloride or a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.
",0,data/dev/EP3312182A1.txt,1
7626,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 → Example 2 → Example 15 was carried out by using a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, and using 1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl-4-boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.
",0,data/dev/EP3312182A1.txt,1
7643,"<img> id-imgb0064.tif </img>
",1,data/dev/EP3312182A1.txt,0
7658,"Reference Example 21: 2,4-Dichloro-7-(difluoromethyl)-7H-pyrrolo[2,3-d]pyrimidine
",1,data/dev/EP3312182A1.txt,0
7681,"A similar procedure to Reference Example 23 → Reference Example 24 → Reference Example 25 → Reference Example 26 → Reference Example 27 → Reference Example 28 → Example 2 was carried out by using 4-amino-3-fluoro-N,N-dimethylbenzamide or a corresponding amine compound instead of 4-amino-3-fluoro-N,N-dimethylbenzamide, and using 1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole instead of 4-benzyloxyphenylboronic acid to give the compound of the present invention having the following physical properties. Meanwhile, HPLC preparative purification was performed instead of silica gel column chromatography in Example 2.
",0,data/dev/EP3312182A1.txt,1
7693,"Reaction Buffer: A solution containing 50 mmol/L HEPES (pH 7.5), 0.01% Brij 35, 10 mmol/L MgCl2 and 1 mmol/L EGTA was prepared by using purified water.
",0,data/dev/EP3312182A1.txt,1
7744,"N6-(1,3-dimethyl-1H-pyrazol-4-yl)-3-(1H-indol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine ... 100 gCarboxymethyl cellulose calcium (a disintegrating agent) ... 20 gMagnesium stearate (a lubricant) ... 10 gMicrocrystalline cellulose ... 870 g
",0,data/dev/EP3312182A1.txt,1
7846,"4-Bromo-3-nitrobenzoic acid is reduced to obtain compound 5-2,which is then esterified with methanesulfonyl chloride to obtain compound 5-3; thionation reaction occurs between compound 5-3 and potassium thioacetate to obtain compound 5-4, which then reacts with N-chlorosuccinimide to produce sulfonyl chloride product 5-5; compound 5-5 reacts with cyclopropylamine to obtain compound 5-6, which then reacts with 3-thienylboric acid to obtain compound 5-7; compound 5-7 is reduced to obtain compound 5-8, and a urea-forming reaction occurs between compound 5-8 and 3-trifluoromethylphenyl isocyanate to obtain the compound of formula VIII.
",0,data/dev/EP3330263A1.txt,1
7856,"<img> id-imgb0045.tif </img>
",0,data/dev/EP3330263A1.txt,1
7870,"Example 2: 2,2-Difluoro-2-(4-(thiophen-3-yl)-3-(3-(3-trifluoromethyl)phenyl)ureido)phenyl)-N-(2,2,2-trifluoroethyl)acetamide
",1,data/dev/EP3330263A1.txt,0
7906,"Example 14: N-cyclopropyl-2-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) propanamide
",0,data/dev/EP3330263A1.txt,1
7908,"<img> id-imgb0059.tif </img>
",0,data/dev/EP3330263A1.txt,1
7932,"<img> id-imgb0064.tif </img>
",1,data/dev/EP3330263A1.txt,0
7946,"Example 23: N-cyclopropyl-4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)benzamide
",0,data/dev/EP3330263A1.txt,1
7947,"<img> id-imgb0069.tif </img>
",0,data/dev/EP3330263A1.txt,1
7959,"Example 24: 1-(5-(1-(cyclopropylamino)ethyl)-2-(thiophen-3-yl)phenyl)-3-(3-(trifluoromethyl) phenyl)urea
",0,data/dev/EP3330263A1.txt,1
7961,"<img> id-imgb0071.tif </img>
",0,data/dev/EP3330263A1.txt,1
7974,"Example 26: N-cyclopropyl-1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) methanesulfonamide
",0,data/dev/EP3330263A1.txt,1
7975,"<img> id-imgb0074.tif </img>
",0,data/dev/EP3330263A1.txt,1
7993,"Example 27: N-(1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)uredio)phenyl)ethyl) cyclopropanecarboxamide
",0,data/dev/EP3330263A1.txt,1
7995,"<img> id-imgb0076.tif </img>
",0,data/dev/EP3330263A1.txt,1
8247,"Embodiment 1
",1,data/dev/US20200055807A1.txt,0
8249,"The chemical reaction of the above alcoholysis process is as follows:
",1,data/dev/US20200055807A1.txt,0
8250,"<img> id-US20200055807A1_00017.PNG </img>
",1,data/dev/US20200055807A1.txt,0
8253,"Embodiment 2
",1,data/dev/US20200055807A1.txt,0
8254,"It differs from Embodiment 1 in that after the amount of each material in Embodiment 1 is increased by 100 times, an alcoholysis reaction is carried out by using a 500 mL pressure reactor, and the filtrate is concentrated to obtain a pure product of 4.648 g, with a yield of 94%. The yield of Embodiment 2 is higher than that of Embodiment 1, because the adhesion loss is large in the operation of small-amount reaction of Embodiment 1, and the yield in large-amount reaction is more accurate.
",1,data/dev/US20200055807A1.txt,0
8255,"Embodiment 3
",1,data/dev/US20200055807A1.txt,0
8256,"It differs from Embodiment 1 in that the molar ratio of methyl glycidyl ether b1 to a1 is 5:1, and the yield is 93%.
",1,data/dev/US20200055807A1.txt,0
8257,"Embodiment 4
",1,data/dev/US20200055807A1.txt,0
8258,"It differs from Embodiment 1 in that the molar ratio of methyl glycidyl ether b1 to a1 is 1:1, and the yield is 69%.
",1,data/dev/US20200055807A1.txt,0
8259,"Embodiment 5
",1,data/dev/US20200055807A1.txt,0
8260,"It differs from Embodiment 1 in that the molar ratio of methyl glycidyl ether b1 to a1 is 8:1, and the yield is 94%.
",1,data/dev/US20200055807A1.txt,0
8261,"Embodiment 6
",1,data/dev/US20200055807A1.txt,0
8262,"It differs from Embodiment 1 in that the Schlenck tube is heated in an oil bath at 80° C. for 35 hours, and the product yield is 84%.
",1,data/dev/US20200055807A1.txt,0
8263,"Embodiment 7
",1,data/dev/US20200055807A1.txt,0
8264,"It differs from Embodiment 1 in that the Schlenck tube is heated in an oil bath at 100° C. for 35 hours, and the product yield is 91%.
",1,data/dev/US20200055807A1.txt,0
8265,"Embodiment 8
",1,data/dev/US20200055807A1.txt,0
8266,"It differs from Embodiment 1 in that the Schlenck tube is heated in an oil bath at 150° C. for 35 hours, and the product yield is 82%.
",1,data/dev/US20200055807A1.txt,0
8267,"Embodiment 9
",1,data/dev/US20200055807A1.txt,0
8268,"It differs from Embodiment 1 in that the Schlenck tube is heated in an oil bath at 50° C. for 35 hours, and the product yield is 48%.
",1,data/dev/US20200055807A1.txt,0
8269,"Embodiment 10
",1,data/dev/US20200055807A1.txt,0
8270,"It differs from Embodiment 1 in that the Schlenck tube is heated in an oil bath at 165° C. for 35 hours, and the product yield is 74%.
",1,data/dev/US20200055807A1.txt,0
8271,"Embodiment 11
",1,data/dev/US20200055807A1.txt,0
8272,"It differs from Embodiment 1 in that the pH adjuster used is CF3CO2K, and the product yield is 93%.
",1,data/dev/US20200055807A1.txt,0
8273,"Embodiment 12
",1,data/dev/US20200055807A1.txt,0
8274,"It differs from Embodiment 1 in that the pH adjuster used is KHCO3, and the product yield is 74%.
",1,data/dev/US20200055807A1.txt,0
8275,"Embodiment 13
",1,data/dev/US20200055807A1.txt,0
8276,"It differs from Embodiment 1 in that the pH adjuster used is K2HPO4, and the product yield is 51%.
",1,data/dev/US20200055807A1.txt,0
8277,"Embodiment 14
",1,data/dev/US20200055807A1.txt,0
8278,"It differs from Embodiment 1 in that the pH adjuster used is K2CO3, and the product yield is 22%.
",1,data/dev/US20200055807A1.txt,0
8279,"Embodiment 15
",1,data/dev/US20200055807A1.txt,0
8281,"Embodiment 16
",1,data/dev/US20200055807A1.txt,0
8283,"Embodiment 17
",1,data/dev/US20200055807A1.txt,0
8285,"Embodiment 18
",1,data/dev/US20200055807A1.txt,0
8287,"Embodiment 19
",1,data/dev/US20200055807A1.txt,0
8289,"Embodiment 20
",1,data/dev/US20200055807A1.txt,0
8291,"Embodiment 21
",1,data/dev/US20200055807A1.txt,0
8293,"Embodiment 22
",1,data/dev/US20200055807A1.txt,0
8295,"Embodiment 23
",1,data/dev/US20200055807A1.txt,0
8297,"Embodiment 24
",1,data/dev/US20200055807A1.txt,0
8299,"Embodiment 25
",1,data/dev/US20200055807A1.txt,0
8300,"It differs from Embodiment 1 in that the solvent used is methanol, and the product yield is 91%.
",1,data/dev/US20200055807A1.txt,0
8303,"Embodiment 26
",1,data/dev/US20200055807A1.txt,0
8304,"It differs from Embodiment 1 in that the solvent used is isopropanol, and the product yield is 95%.
",1,data/dev/US20200055807A1.txt,0
8307,"Embodiment 27
",1,data/dev/US20200055807A1.txt,0
8308,"It differs from Embodiment 1 in that the solvent used is isobutanol, and the product yield is 92%.
",1,data/dev/US20200055807A1.txt,0
8311,"Embodiment 28
",1,data/dev/US20200055807A1.txt,0
8312,"It differs from Embodiment 1 in that the solvent used is isoamyl alcohol, and the product yield is 87%.
",1,data/dev/US20200055807A1.txt,0
8315,"Embodiment 29
",1,data/dev/US20200055807A1.txt,0
8317,"Embodiment 30
",1,data/dev/US20200055807A1.txt,0
8319,"Embodiment 31
",1,data/dev/US20200055807A1.txt,0
8321,"Embodiment 32
",1,data/dev/US20200055807A1.txt,0
8322,"It differs from Embodiment 1 in that the amide compound used is a2, and the yield is 96%.
",1,data/dev/US20200055807A1.txt,0
8325,"Embodiment 33
",1,data/dev/US20200055807A1.txt,0
8326,"It differs from Embodiment 1 in that the amide compound used is a3, and the yield is 41%.
",1,data/dev/US20200055807A1.txt,0
8327,"Embodiment 34
",1,data/dev/US20200055807A1.txt,0
8328,"It differs from Embodiment 1 in that the amide compound used is a4, and the yield is 97%.
",1,data/dev/US20200055807A1.txt,0
8329,"Embodiment 35
",1,data/dev/US20200055807A1.txt,0
8330,"It differs from Embodiment 1 in that the amide compound used is a5, and the yield is 96%.
",1,data/dev/US20200055807A1.txt,0
8331,"Embodiment 36
",1,data/dev/US20200055807A1.txt,0
8332,"It differs from Embodiment 1 in that the amide compound used is a6, and the yield is 93%.
",1,data/dev/US20200055807A1.txt,0
8333,"Embodiment 37
",1,data/dev/US20200055807A1.txt,0
8334,"It differs from Embodiment 1 in that the amide compound used is a7, and the yield is 90%.
",1,data/dev/US20200055807A1.txt,0
8335,"Embodiment 38
",1,data/dev/US20200055807A1.txt,0
8336,"It differs from Embodiment 1 in that the amide compound used is a8, and the yield is 62%.
",1,data/dev/US20200055807A1.txt,0
8339,"Embodiment 39
",1,data/dev/US20200055807A1.txt,0
8340,"It differs from Embodiment 1 in that the amide compound used is a9, and the yield is 91%.
",1,data/dev/US20200055807A1.txt,0
8343,"Embodiment 40
",1,data/dev/US20200055807A1.txt,0
8344,"It differs from Embodiment 1 in that the amide compound used is a10, and the yield is 97%.
",1,data/dev/US20200055807A1.txt,0
8345,"Embodiment 41
",1,data/dev/US20200055807A1.txt,0
8346,"It differs from Embodiment 1 in that the amide compound used is all, and the yield is 94%.
",1,data/dev/US20200055807A1.txt,0
8349,"Embodiment 42
",1,data/dev/US20200055807A1.txt,0
8350,"It differs from Embodiment 1 in that the amide compound used is a12, and the yield is 90%.
",1,data/dev/US20200055807A1.txt,0
8353,"Embodiment 43
",1,data/dev/US20200055807A1.txt,0
8354,"It differs from Embodiment 1 in that the amide compound used is a13, and the yield is 89%.
",1,data/dev/US20200055807A1.txt,0
8358,"Embodiment 44
",1,data/dev/US20200055807A1.txt,0
8362,"Embodiment 45
",1,data/dev/US20200055807A1.txt,0
8366,"Embodiment 46
",1,data/dev/US20200055807A1.txt,0
8370,"Embodiment 47
",1,data/dev/US20200055807A1.txt,0
8374,"Embodiment 48
",1,data/dev/US20200055807A1.txt,0
8378,"Embodiment 49
",1,data/dev/US20200055807A1.txt,0
8382,"Embodiment 50
",1,data/dev/US20200055807A1.txt,0
8386,"Embodiment 51
",1,data/dev/US20200055807A1.txt,0
8390,"Embodiment 52
",1,data/dev/US20200055807A1.txt,0
8394,"Embodiment 53
",1,data/dev/US20200055807A1.txt,0
8398,"Embodiment 54
",1,data/dev/US20200055807A1.txt,0
8402,"Embodiment 55
",1,data/dev/US20200055807A1.txt,0
8406,"Embodiment 56
",1,data/dev/US20200055807A1.txt,0
8410,"Embodiment 57
",1,data/dev/US20200055807A1.txt,0
8414,"Embodiment 58
",1,data/dev/US20200055807A1.txt,0
8418,"Embodiment 59
",1,data/dev/US20200055807A1.txt,0
8422,"Embodiment 60
",1,data/dev/US20200055807A1.txt,0
8423,"It differs from Embodiment 1 in that the epoxy compound used is b2, and the yield is 92%.
",1,data/dev/US20200055807A1.txt,0
8424,"Embodiment 61
",1,data/dev/US20200055807A1.txt,0
8425,"It differs from Embodiment 1 in that the epoxy compound used is b3, and the yield is 69%.
",1,data/dev/US20200055807A1.txt,0
8426,"Embodiment 62
",1,data/dev/US20200055807A1.txt,0
8427,"It differs from Embodiment 1 in that the epoxy compound used is b4, and the yield is 21%.
",1,data/dev/US20200055807A1.txt,0
8428,"Embodiment 63
",1,data/dev/US20200055807A1.txt,0
8429,"It differs from Embodiment 1 in that the epoxy compound used is b5, and the yield is 68%.
",1,data/dev/US20200055807A1.txt,0
8430,"Embodiment 64
",1,data/dev/US20200055807A1.txt,0
8431,"It differs from Embodiment 1 in that the epoxy compound used is b6, and the yield is 87%.
",1,data/dev/US20200055807A1.txt,0
8432,"Embodiment 65
",1,data/dev/US20200055807A1.txt,0
8433,"It differs from Embodiment 1 in that the epoxy compound used is b7, and the yield is 89%.
",1,data/dev/US20200055807A1.txt,0
8434,"Embodiment 66
",1,data/dev/US20200055807A1.txt,0
8435,"It differs from Embodiment 1 in that the epoxy compound used is b8, and the yield is 47%.
",1,data/dev/US20200055807A1.txt,0
8490,"Then, ethyl acetoacetate (Compound 4) in which the alpha position is substituted is synthesized by allowing Compound 3 to react with tributyltinhydride (n-Bu3SnH) in a toluene solvent. Then, an oxime (Compound 5) is synthesized by adding butyl nitrite (n-BuONO) to Compound 4 in the presence of an ethanolic ethoxide base. After Compound 6 was obtained by reacting Compound 5 with dihydropyran (DHP) in the presence of a p-toluenesulfonic acid (p-TsOH) catalyst, Compound 7 is synthesized by performing hydrolysis with an aqueous potassium hydroxide (1 N-KOH) solution in an ethanol solvent. Then, Compound 8 (a compound of Chemical Formula 3) is synthesized by a condensation reaction with N-hydroxysuccinimide and Compound 7 in a dioxane solvent (1,4-dioxane). Compound 9 (a compound of Chemical Formula 4) is produced by allowing 2,2'-diselanediyldiethanamine to react with synthesized Compound 8 (a compound of Chemical Formula 3) in the presence of a triethylamine (TEA) base, subsequently, a selenopsammaplin A derivative (Compound 1, a compound of Chemical Formula 1) is synthesized by performing a hydrolysis reaction using a hydrochloric acid (1 M-HCl) ether (Et2O) solution as an acid catalyst, phenyl disulfide, dithiothreitol, and a phosphoric acid buffer are dissolved in a dimethyl sulfoxide solvent, and then a selenopsammaplin A derivative (Compound 10, a compound of Chemical Formula 2) is synthesized by diluting the reaction product thereof with ethyl acetate and separating the reaction product thereof with column chromatography.
",0,data/dev/EP3708563A1.txt,1
8527,"Further, in the present Examples 1 to 28, a selenopsammaplin A monomer derivative as illustrated in FIG. 1B is prepared, and the compounds in Examples 1 to 28 are prepared according to the above-described Reaction Scheme 1 (FIG. 2). First, after synthesized selenopsammaplin A (1,133 mg) which is a substrate, phenyl disulfide (44.2 mg), and dithiothreitol (3.2 mg) were dissolved in a pH 8.3 phosphoric acid buffer (2 mL) and a dimethyl sulfoxide solvent (6 mL), the resulting solution was stirred at room temperature for 16 hours. After completion of the reaction, a selenopsammaplin A monomer (SSM-15, 35 mg) was obtained by separating the residue obtained by diluting the reaction solution with ethyl acetate (50 mL), washing the diluted reaction solution with water (10 mL x 10), and distilling the resulting product under reduced pressure.
",1,data/dev/EP3708563A1.txt,0
8759,"<img> id-US20180105741A1-20180419-C00177.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8787,"<img> id-US20180105741A1-20180419-C00178.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8789,"<img> id-US20180105741A1-20180419-C00179.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8791,"<img> id-US20180105741A1-20180419-C00180.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8793,"<img> id-US20180105741A1-20180419-C00181.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8795,"<img> id-US20180105741A1-20180419-C00182.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8815,"<img> id-US20180105741A1-20180419-C00190.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8841,"<img> id-US20180105741A1-20180419-C00191.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8864,"<img> id-US20180105741A1-20180419-C00205.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8889,"<img> id-US20180105741A1-20180419-C00206.TIF </img><img> id-US20180105741A1-20180419-C00207.TIF </img><img> id-US20180105741A1-20180419-C00208.TIF </img><img> id-US20180105741A1-20180419-C00209.TIF </img><img> id-US20180105741A1-20180419-C00210.TIF </img><img> id-US20180105741A1-20180419-C00211.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8893,"<img> id-US20180105741A1-20180419-C00212.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8912,"<img> id-US20180105741A1-20180419-C00213.TIF </img><img> id-US20180105741A1-20180419-C00214.TIF </img><img> id-US20180105741A1-20180419-C00215.TIF </img><img> id-US20180105741A1-20180419-C00216.TIF </img><img> id-US20180105741A1-20180419-C00217.TIF </img><img> id-US20180105741A1-20180419-C00218.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8914,"<img> id-US20180105741A1-20180419-C00219.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8941,"<img> id-US20180105741A1-20180419-C00220.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8959,"<img> id-US20180105741A1-20180419-C00221.TIF </img><img> id-US20180105741A1-20180419-C00222.TIF </img><img> id-US20180105741A1-20180419-C00223.TIF </img><img> id-US20180105741A1-20180419-C00224.TIF </img><img> id-US20180105741A1-20180419-C00225.TIF </img><img> id-US20180105741A1-20180419-C00226.TIF </img><img> id-US20180105741A1-20180419-C00227.TIF </img><img> id-US20180105741A1-20180419-C00228.TIF </img><img> id-US20180105741A1-20180419-C00229.TIF </img><img> id-US20180105741A1-20180419-C00230.TIF </img><img> id-US20180105741A1-20180419-C00231.TIF </img><img> id-US20180105741A1-20180419-C00232.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8961,"<img> id-US20180105741A1-20180419-C00233.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8967,"<img> id-US20180105741A1-20180419-C00234.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8995,"<img> id-US20180105741A1-20180419-C00235.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9030,"<img> id-US20180105741A1-20180419-C00236.TIF </img><img> id-US20180105741A1-20180419-C00237.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9049,"Synthesis Example 2: Synthesis of Compound 41
",1,data/dev/US20180105741A1.txt,0
9055,"Synthesis Example 3: Synthesis of Compound 42
",1,data/dev/US20180105741A1.txt,0
9061,"Synthesis Example 4: Synthesis of Compound 43
",1,data/dev/US20180105741A1.txt,0
9067,"Synthesis Example 5: Synthesis of Compound 44
",1,data/dev/US20180105741A1.txt,0
9073,"Synthesis Example 6: Synthesis of Compound 45
",1,data/dev/US20180105741A1.txt,0
9079,"Synthesis Example 7: Synthesis of Compound 46
",1,data/dev/US20180105741A1.txt,0
9085,"Synthesis Example 8: Synthesis of Compound 47
",1,data/dev/US20180105741A1.txt,0
9091,"Synthesis Example 9: Synthesis of Compound 355
",1,data/dev/US20180105741A1.txt,0
9111,"Synthesis Example 10: Synthesis of Compound 356
",1,data/dev/US20180105741A1.txt,0
9117,"Synthesis Example 11: Synthesis of Compound 357
",1,data/dev/US20180105741A1.txt,0
9123,"Synthesis Example 12: Synthesis of Compound 358
",1,data/dev/US20180105741A1.txt,0
9129,"Synthesis Example 13: Synthesis of Compound 359
",1,data/dev/US20180105741A1.txt,0
9135,"Synthesis Example 14: Synthesis of Compound 360
",1,data/dev/US20180105741A1.txt,0
9141,"Synthesis Example 15: Synthesis of Compound 361
",1,data/dev/US20180105741A1.txt,0
9147,"Synthesis Example 16: Synthesis of Compound 362
",1,data/dev/US20180105741A1.txt,0
9153,"Synthesis Example 17: Synthesis of Compound 363
",1,data/dev/US20180105741A1.txt,0
9162,"<img> id-US20180105741A1-20180419-C00239.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9166,"Example 9
",0,data/dev/US20180105741A1.txt,1
9260,"<img> id-US20180105741A1-20180419-C00240.TIF </img><img> id-US20180105741A1-20180419-C00241.TIF </img><img> id-US20180105741A1-20180419-C00242.TIF </img><img> id-US20180105741A1-20180419-C00243.TIF </img><img> id-US20180105741A1-20180419-C00244.TIF </img><img> id-US20180105741A1-20180419-C00245.TIF </img><img> id-US20180105741A1-20180419-C00246.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9271,"Article titled “Direct synthesis of pyridines and quinolines by coupling of γ-amino-alcohols with secondary alcohols liberating H2 catalyzed by ruthenium pincer complexes” by D Srimani et al. published in Chem. Commun., 2013, 49, 6632-6634 reports a novel, one-step synthesis of substituted pyridine- and quinoline-derivatives was achieved by acceptorless dehydrogenative coupling of γ-aminoalcohols with secondary alcohols. The reaction involves consecutive C—N and C—C bond formation, catalyzed by a bipyridyl-based ruthenium pincer complex with a base.
",0,data/dev/US20200384451A1.txt,1
9348,"a) Dimer of Co(II)chloride:bis(2-(diethyl-λ3-sulfanyl)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9349,"<img> id-US20200384451A1_00008.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9352,"b) Dimer of Co(II)chloride:bis(2-(isopropylthio)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9353,"<img> id-US20200384451A1_00009.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9356,"c) Dimer of Co(II)bromide:bis(2-(diethyl-λ3-sulfanyl)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9357,"<img> id-US20200384451A1_00010.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9359,"d) Dimer of Co(II)bromide:bis(2-(isopropylthio)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9360,"<img> id-US20200384451A1_00011.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9364,"<img> id-US20200384451A1_00012.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9365,"<table>
",1,data/dev/US20200384451A1.txt,0
9366,"<header>
",1,data/dev/US20200384451A1.txt,0
9367,"TABLE 1
",1,data/dev/US20200384451A1.txt,0
9368,"</header>
",1,data/dev/US20200384451A1.txt,0
9369,"<header>
",1,data/dev/US20200384451A1.txt,0
9370,"
",1,data/dev/US20200384451A1.txt,0
9371,"</header>
",1,data/dev/US20200384451A1.txt,0
9372,"<header>
",1,data/dev/US20200384451A1.txt,0
9374,"</header>
",1,data/dev/US20200384451A1.txt,0
9375,"<header>
",1,data/dev/US20200384451A1.txt,0
9376,"
",1,data/dev/US20200384451A1.txt,0
9377,"</header>
",1,data/dev/US20200384451A1.txt,0
9378,"1 & Toluene & 47
",1,data/dev/US20200384451A1.txt,0
9379,"2 & m-xylene & 77
",1,data/dev/US20200384451A1.txt,0
9380,"3 & Mesitylene & 57
",1,data/dev/US20200384451A1.txt,0
9381,"4 & n-octane & 52
",1,data/dev/US20200384451A1.txt,0
9384,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9385,"</table>
",1,data/dev/US20200384451A1.txt,0
9387,"<img> id-US20200384451A1_00013.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9388,"<table>
",1,data/dev/US20200384451A1.txt,0
9389,"<header>
",1,data/dev/US20200384451A1.txt,0
9390,"TABLE 2
",1,data/dev/US20200384451A1.txt,0
9391,"</header>
",1,data/dev/US20200384451A1.txt,0
9392,"<header>
",1,data/dev/US20200384451A1.txt,0
9393,"
",1,data/dev/US20200384451A1.txt,0
9394,"</header>
",1,data/dev/US20200384451A1.txt,0
9395,"<header>
",1,data/dev/US20200384451A1.txt,0
9397,"</header>
",1,data/dev/US20200384451A1.txt,0
9398,"<header>
",1,data/dev/US20200384451A1.txt,0
9399,"
",1,data/dev/US20200384451A1.txt,0
9400,"</header>
",1,data/dev/US20200384451A1.txt,0
9401,"1 & Cat. 1 & 77
",1,data/dev/US20200384451A1.txt,0
9402,"2 & Cat. 2 & 34
",1,data/dev/US20200384451A1.txt,0
9403,"3 & CoCl2 & trace
",1,data/dev/US20200384451A1.txt,0
9404,"4 & — & NR
",1,data/dev/US20200384451A1.txt,0
9405,"5 & RuCl2(PPh3)[HN(C2H4SEt)2] & 45
",1,data/dev/US20200384451A1.txt,0
9407,"bYield determined by GC using 1,4-dibromo butane as an internal standard. NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9408,"</table>
",1,data/dev/US20200384451A1.txt,0
9409,"c) Reaction with Different Basea
",1,data/dev/US20200384451A1.txt,0
9410,"<table>
",1,data/dev/US20200384451A1.txt,0
9411,"<header>
",1,data/dev/US20200384451A1.txt,0
9412,"
",1,data/dev/US20200384451A1.txt,0
9413,"</header>
",1,data/dev/US20200384451A1.txt,0
9414,"<img> id-US20200384451A1_00014.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9415,"<img> id-US20200384451A1_00015.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9416,"<img> id-US20200384451A1_00016.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9417,"Entry & Base & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9418,"1 & NaOtBu & 63
",1,data/dev/US20200384451A1.txt,0
9419,"2 & NaOiPr & 17
",1,data/dev/US20200384451A1.txt,0
9420,"3 & KOH & 62
",1,data/dev/US20200384451A1.txt,0
9421,"4 & KOtBu & 77
",1,data/dev/US20200384451A1.txt,0
9422,"5 & KHMDS & 67
",1,data/dev/US20200384451A1.txt,0
9423,"6 & KH & 71
",1,data/dev/US20200384451A1.txt,0
9424,"7 & K2CO3 & NR
",1,data/dev/US20200384451A1.txt,0
9425,"8 & KOAc & NR
",1,data/dev/US20200384451A1.txt,0
9426,"9 & — & NR
",1,data/dev/US20200384451A1.txt,0
9428,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9429,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9430,"</table>
",1,data/dev/US20200384451A1.txt,0
9431,"d) Reaction with Different Base Amounta
",1,data/dev/US20200384451A1.txt,0
9432,"<table>
",1,data/dev/US20200384451A1.txt,0
9433,"<header>
",1,data/dev/US20200384451A1.txt,0
9434,"
",1,data/dev/US20200384451A1.txt,0
9435,"</header>
",1,data/dev/US20200384451A1.txt,0
9437,"<img> id-US20200384451A1_00018.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9438,"<img> id-US20200384451A1_00019.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9440,"1 & 0.5 eq & 20
",1,data/dev/US20200384451A1.txt,0
9441,"2 & 1.1 eq & 77
",1,data/dev/US20200384451A1.txt,0
9442,"3 & 1.5 eq & 55
",1,data/dev/US20200384451A1.txt,0
9444,"5 & 2.5 eq & 35
",1,data/dev/US20200384451A1.txt,0
9446,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9447,"</table>
",1,data/dev/US20200384451A1.txt,0
9448,"e) Reaction with Different Temperaturea
",1,data/dev/US20200384451A1.txt,0
9449,"<table>
",1,data/dev/US20200384451A1.txt,0
9450,"<header>
",1,data/dev/US20200384451A1.txt,0
9451,"
",1,data/dev/US20200384451A1.txt,0
9452,"</header>
",1,data/dev/US20200384451A1.txt,0
9453,"<img> id-US20200384451A1_00020.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9454,"<img> id-US20200384451A1_00021.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9457,"1 & 50° C. & NR
",1,data/dev/US20200384451A1.txt,0
9458,"2 & 80° C. & trace
",1,data/dev/US20200384451A1.txt,0
9459,"3 & 120° C. & 23
",1,data/dev/US20200384451A1.txt,0
9460,"4 & 150° C. & 48
",1,data/dev/US20200384451A1.txt,0
9461,"5 & 180° C. & 77
",1,data/dev/US20200384451A1.txt,0
9462," & (reflux)
",1,data/dev/US20200384451A1.txt,0
9464,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9465,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9466,"</table>
",1,data/dev/US20200384451A1.txt,0
9468,"<table>
",1,data/dev/US20200384451A1.txt,0
9469,"<header>
",1,data/dev/US20200384451A1.txt,0
9470,"
",1,data/dev/US20200384451A1.txt,0
9471,"</header>
",1,data/dev/US20200384451A1.txt,0
9473,"<img> id-US20200384451A1_00024.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9474,"<img> id-US20200384451A1_00025.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9475," & Alcohol/amino & 
",1,data/dev/US20200384451A1.txt,0
9477,"1 & 1/1 & 69
",1,data/dev/US20200384451A1.txt,0
9478,"2 & 1/1 (cat 2) & 67
",1,data/dev/US20200384451A1.txt,0
9479,"3 & 1.5/1 & 71
",1,data/dev/US20200384451A1.txt,0
9480,"4 & 2/1 & 77
",1,data/dev/US20200384451A1.txt,0
9481,"5 & 3/1 & 65
",1,data/dev/US20200384451A1.txt,0
9483,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9484,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9485,"</table>
",1,data/dev/US20200384451A1.txt,0
9500,"vi. 2,5-diphenyl-1H-pyrrole (5f)
",1,data/dev/US20200384451A1.txt,0
9514,"xiii. 2-isopropyl-5-(naphthalen-1-yl)-1H-pyrrole (5m)
",1,data/dev/US20200384451A1.txt,0
9516,"xiv. 2-isopropyl-5-octyl-1H-pyrrole (5n)
",1,data/dev/US20200384451A1.txt,0
9529,"iv. 2-m-tolylpyridine (7d)
",1,data/dev/US20200384451A1.txt,0
9531,"v. 2-octyl Pyridine (7e)
",1,data/dev/US20200384451A1.txt,0
9532,"Ration of alcohol/amino alcohol=1.5/1 has taken under the identical reaction condition.
",1,data/dev/US20200384451A1.txt,0
9534,"vi. 2-decyl Pyridine (7f)
",1,data/dev/US20200384451A1.txt,0
9536,"vii. 2-phenyl Quinoline (7g)
",1,data/dev/US20200384451A1.txt,0
9538,"viii. 2-(3-methoxyphenyl) Quinoline (7h)
",1,data/dev/US20200384451A1.txt,0
9544,"xi. 2-(naphthalen-2-yl)quinoline (7k)
",1,data/dev/US20200384451A1.txt,0
9549,"a. 2,5-Diphenyl Pyrazine (8)
",1,data/dev/US20200384451A1.txt,0
9780,"Synthesis Example
",0,data/dev/US20200181061A1.txt,1
9784,"<img> id-US20200181061A1_00016.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9790,"<img> id-US20200181061A1_00018.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9793,"<img> id-US20200181061A1_00019.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9796,"<img> id-US20200181061A1_00020.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9799,"<img> id-US20200181061A1_00021.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9811,"<img> id-US20200181061A1_00025.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9858,"<img> id-US20200181061A1_00031.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9861,"<img> id-US20200181061A1_00032.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9864,"<img> id-US20200181061A1_00033.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9867,"<img> id-US20200181061A1_00034.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9872,"<img> id-US20200181061A1_00035.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9875,"<img> id-US20200181061A1_00036.PNG </img>
",0,data/dev/US20200181061A1.txt,1
9888,"<Production of Compound Lens>
",0,data/dev/US20200181061A1.txt,1
10035,"<img> id-US20200164075A1_00027.PNG </img>
",0,data/dev/US20200164075A1.txt,1
10039,"<img> id-US20200164075A1_00029.PNG </img>
",0,data/dev/US20200164075A1.txt,1
10155,"In an embodiment in FIG. 16, Solid phase peptide synthesis of AAPT rhodamine B conjugate 25. The arene rhodamine B conjugate 25 is synthesized using SPPS by introduction of 4-carboxylic acid benzylamine in the peptide spacer to enhance the binding affinity to PSMA protein. 1,2-diaminoethanetrityl resin (0.050 g, 0.0525 mmol) was swelled initially with CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (0.054 g, 0.1312 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Fmoc-Lys(Tfa)-OH, Fmoc-8-aminocaprylic acid, Fmoc benzylamine-4-carboxylic acid, Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of Fmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tert butyl protected AAPT ligand 16a (0.040 g, 0.079 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the resin beads and mixed for 6 h. The completion of coupling reaction was confirmed by performing the Kaiser test. Finally, the trifluoroacetyl (Tfa) protecting group of lysine amino acid was cleaved with 2M aqueous piperidine (10 mL) at room temperature for 6-12 h (depending on completion of the reaction) and the deprotection of Tfa group was confirmed by the Kaiser test. Rhodamine B dye (0.038 g, 0.079 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the peptide vessel and reacted for 6 h at room temperature. The completion of the coupling reaction was confirmed by performing the Kaiser test. A mixture of 9.5 mL trifluoroacetic acid (TFA), 0.25 mL triisopropylsilane (TIPS), and 0.25 mL H2O was prepared in a 15 mL centrifuge tube, and 5 mL of this cocktail solution was added to the resin beads and nitrogen gas was bubbled through the solution for 30 minutes. The cocktail with cleaved rhodamine peptide conjugate in peptide vessel was collected to a round bottom flask (25 mL). The resin beads were treated again with the cocktail solution twice (2.5 mL×2) for 15 minutes each and the mother liquor was collected in the same round bottom flask (25 mL). The pooled cocktail mixture with cleaved peptide arene rhodamine B conjugate 25 was transferred to a 15 mL centrifuge tube, fitted with a septum and concentrated under reduced pressure to obtain a viscous liquid. Ice cold ether (5 mL) was added to the concentrated viscous mixture to precipitate arene rhodamine B conjugate 25 as a bright red solid and the solid was washed thrice with ice cold ether (5 mL×3). The crude product 25 was purified by RP-HPLC using pentafluorophenyl preparative column (5 μm, 10 mm×150 mm) [λ=555 nm; solvent gradient 1% B to 70% B in 25 min, 80% B wash 15 min; A=0.1% TFA, pH=2; B=acetonitrile (ACN)]. Acetonitrile was removed reduced pressure from HPLC fractions, and the pure fractions were freeze-dried to yield peptide arene rhodamine B conjugate 25 as pink solid. The purity of arene rhodamine B conjugate 25 was confirmed by analytical RP-HPLC and the molecular weight is determined by HRMS (+ESI) calcd for [M−Cl]+ (C94H125N14O19)+: 1753.9245 found 1753.9239.
",0,data/dev/US20200164075A1.txt,1
10158,"In an embodiment in FIG. 18, Solid phase synthesis of AAPT ligand conjugated chelating linker 31.H-Cys-2-ClTrt resin (0.100 g, 0.09 mmol) was swelled in CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL×3) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (93 mg, 0.225 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Boc-Dap(Fmoc)-OH, Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of NHFmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tertbutyl protected compound 16a (68 mg, 0.135 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) were added to the vessel and mixed for 6 h. The completion of reaction was confirmed by the Kaiser test.
",0,data/dev/US20200164075A1.txt,1
10161,"In an embodiment in FIG. 19, Solid phase synthetic procedure for preparation of AAPT ligand conjugated arene chelating linker 34. H-Cys-2-ClTrt resin (0.100 g, 0.09 mmol) was swelled in CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL×3) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (93 mg, 0.225 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Boc-Dap(Fmoc)-OH, Fmoc-8-aminocaprylic acid, 4-(Fmoc-aminomethyl) benzoic acid Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of NHFmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tertbutyl protected compound 16a (68 mg, 0.135 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) were added to the vessel and mixed for 6 h. The completion of reaction was confirmed by the Kaiser test.
",0,data/dev/US20200164075A1.txt,1
10205,"The purity of ligands 1-3 were analyzed using a Dionex HPLC-Ultimate 3000 system. Typically a solution of each ligand (20 μL, 1.0 mg/1.0 mL) in a mixture of CH3CN:H2O (1:1) was injected via autosampler and eluted using Dionex Acclaim® 120 C18, 5 μm, 4.6 mm×250 mm analytical column at a flow rate of 1 mL/min (mobile phase, A=0.1% trifluoro acetic acid/H2O and B=acetonitrile). An isocratic flow of 40% B (v/v) was used during the run for 0 to 4 min and gradually gradient of B was increased to 100% B (v/v) over a period of 40-min. The chromatogram of each ligand was recorded on the Ultimate 3000 RS variable wavelength detector at 225-280 nm.
",0,data/dev/US20200164075A1.txt,1
10207,"The purification of ligands 1-3 was performed using Buchi Reveleris Preparative HPLC System. Crude ligand (20 mg) was dissolved in 1:1 ratio of CH3CN:H2O (1 mL) and injected into the sample injector for elution using RP-PFP (Reverse Phase pentafluorophenyl) preparative column (XSelect CSH Prep Fluorophenyl 5 μm OBD, 19 mm×150 mm). A flow rate of 10 mL/min (mobile phase, A=0.1% trifluoro acetic acid/H2O and B=acetonitrile) is maintained throughout the run and the mobile phase gradient was increased from 1% B (v/v) to 50% B (v/v) over a period of 40 min. The mobile phase gradient was further increased to 80% B (v/v) in the next 15 min and the chromatogram was recorded at λ=200-254 nm as well as by ELSD detector. Pure fractions of 1-3 were collected using automatic fraction collector, acetonitrile was evaporated under reduced pressure, lyophilized to afford pure ligands 1-3. The pure ligands were further used for GCPII enzyme inhibition assay.
",0,data/dev/US20200164075A1.txt,1
10291,"<img> id-US20200377536A1_00017.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10349,"<img> id-US20200377536A1_00022.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10385,"<img> id-US20200377536A1_00023.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10424,"<img> id-US20200377536A1_00024.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10446,"<img> id-US20200377536A1_00026.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10448,"<First Step>
",1,data/dev/US20200377536A1.txt,0
10452,"<Second Step>
",1,data/dev/US20200377536A1.txt,0
10455,"<Third Step>
",1,data/dev/US20200377536A1.txt,0
10459,"<Fourth Step>
",1,data/dev/US20200377536A1.txt,0
10464,"Example 2
",1,data/dev/US20200377536A1.txt,0
10466,"wherein R1 and R2 represent an adamantyl group.
",1,data/dev/US20200377536A1.txt,0
10470,"Example 3
",1,data/dev/US20200377536A1.txt,0
10471,"<img> id-US20200377536A1_00028.PNG </img>
",1,data/dev/US20200377536A1.txt,0
10472,"wherein R1 represents an adamantyl group, and R2 represents a 1,1,3,3-tetramethylbutyl group.
",1,data/dev/US20200377536A1.txt,0
10476,"Example 4
",1,data/dev/US20200377536A1.txt,0
10478,"wherein R1 represents a tert-butyl group, and R2 represents an adamantyl group.
",1,data/dev/US20200377536A1.txt,0
10485,"wherein R1 represents a tert-butyl group, and R2 represents a 1,1,3,3-tetramethylbutyl group.
",1,data/dev/US20200377536A1.txt,0
10490,"Comparative Example 1
",1,data/dev/US20200377536A1.txt,0
10492,"wherein R1 and R2 represent a tert-butyl group.
",1,data/dev/US20200377536A1.txt,0
10498,"Enantioselective Markovnikov Hydroboration Reaction
",1,data/dev/US20200377536A1.txt,0
10501,"It was confirmed by 1H NMR and 31P NMR that in the reaction liquid, (S)-Quinox-tODAd and Cu(O-t-Bu) formed a complex in a molar ratio of 1:1.
",0,data/dev/US20200377536A1.txt,1
10527,"Example 1
",1,data/dev/US20200377536A1.txt,0
10533,"<img> id-US20200377536A1_00033.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10556,"Example 14 & Ph2MeSiO—(CH2)3— & 52 & 89:11 & 97
",1,data/dev/US20200377536A1.txt,0
10561,"Example 16
",0,data/dev/US20200377536A1.txt,1
10562,"<img> id-US20200377536A1_00034.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10564,"<First Step and Second Step>
",1,data/dev/US20200377536A1.txt,0
10566,"<Ath Step>
",1,data/dev/US20200377536A1.txt,0
10568,"Identification Data of (R)-2-Tert-Butylmethylphosphino-3-diphenylphosphinoquinoxaline (1 g)
",0,data/dev/US20200377536A1.txt,1
10649,"<img> id-US20180008574A1-20180111-C00014.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10652,"<img> id-US20180008574A1-20180111-C00015.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10655,"<img> id-US20180008574A1-20180111-C00016.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10658,"<img> id-US20180008574A1-20180111-C00017.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10661,"<img> id-US20180008574A1-20180111-C00018.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10666,"<img> id-US20180008574A1-20180111-C00019.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10668,"Example 3: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)thiophene-2-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10670,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J=7.2 Hz, 1H), 7.92 (d, J=8.4 Hz, 1H), 7.74-7.58 (m, 1H), 7.52 (d, J=5.2 Hz, 1H), 7.41 (d, J=3.6 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 7.01-6.93 (m, 1H), 6.91 (s, 1H), 6.82 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10676,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J=8.4 Hz, 1H), 8.09 (d, J=7.2 Hz, 1H), 7.78 (t, J=7.6 Hz, 1H), 7.55 (d, J=7.6 Hz, 1H), 7.00-6.72 (m, 2H), 3.96 (q, J=7.2 Hz, 2H), 3.21-2.96 (m, 1H), 2.23 (d, J=112.0 Hz, 2H), 1.87 (d, J=7.6 Hz, 2H), 1.65-1.61 (m, 4H), 1.37 (t, J=7.2 Hz, 3H), 1.19 (d, J=9.2 Hz, 2H).
",1,data/dev/US20180008574A1.txt,0
10679,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.27 (s, 1H), 8.14 (d, J=8.4 Hz, 1H), 8.01 (d, J=7.2 Hz, 1H), 7.86 (d, J=7.2 Hz, 1H), 7.72-7.49 (m, 3H), 7.41 (t, J=7.6 Hz, 1H), 7.33-7.14 (m, 2H), 6.75 (d, J=7.6 Hz, 1H), 4.12 (s, 3H), 3.92 (q, J=7.2 Hz, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10682,"The synthesis of methyl 2-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoate can refer Example 6.
",1,data/dev/US20180008574A1.txt,0
10686,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J=7.2 Hz, 1H), 7.90 (d, J=8.4 Hz, 1H), 7.74 (d, J=7.6 Hz, 2H), 7.60 (t, J=7.6 Hz, 1H), 7.54-7.49 (m, 1H), 7.39 (t, J=7.6 Hz, 2H), 7.21 (d, J=7.6 Hz, 1H), 7.06 (s, 1H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10692,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J=7.2 Hz, 1H), 7.91 (d, J=8.4 Hz, 1H), 7.65 (t, J=7.6 Hz, 1H), 7.66-7.45 (m, 2H), 7.38 (dd, J=13.2, 8.0 Hz, 1H), 7.25 (d, J=4.8 Hz, 1H), 7.20 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10695,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J=8.4 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.80 (t, J=7.6 Hz, 1H), 7.54 (d, J=7.6 Hz, 1H), 6.93-6.76 (m, 2H), 3.97 (q, J=7.2 Hz, 2H), 3.16 (q, J=7.2 Hz, 2H), 1.43 (t, J=7.2 Hz, 3H), 1.37 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10698,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=7.2 Hz, 1H), 7.95 (d, J=8.4 Hz, 1H), 7.79-7.51 (m, 3H), 7.20 (d, J=7.6 Hz, 1H), 6.89 (s, 1H), 6.84 (d, J=8.8 Hz, 2H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10701,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J=7.2 Hz, 1H), 7.89 (d, J=8.4 Hz, 1H), 7.85 (d, J=8.4 Hz, 2H), 7.74-7.57 (m, 3H), 7.17 (d, J=7.6 Hz, 1H), 7.11 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10704,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J=8.8 Hz, 2H), 8.05 (d, J=7.2 Hz, 1H), 7.92 (d, J=9.2 Hz, 3H), 7.67 (t, J=7.6 Hz, 1H), 7.17 (d, J=7.6 Hz, 1H), 6.95 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10707,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J=7.2 Hz, 1H), 7.78 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 2H), 7.60-7.48 (m, 1H), 7.37 (d, J=8.4 Hz, 2H), 7.28 (s, 1H), 6.80 (d, J=7.6 Hz, 2H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H), 1.27 (s, 9H).
",1,data/dev/US20180008574A1.txt,0
10710,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J=7.2 Hz, 1H), 7.86 (d, J=8.4 Hz, 1H), 7.79 (d, J=8.8 Hz, 2H), 7.71-7.53 (m, 1H), 7.23 (d, J=7.6 Hz, 3H), 6.87 (s, 1H), 6.82 (d, J=7.6 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10713,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.82 (s, 1H), 8.12 (d, J=8.4 Hz, 1H), 8.03 (d, J=6.8 Hz, 1H), 7.82 (dd, J=17.6, 10.0 Hz, 1H), 7.76 (d, J=7.2 Hz, 1H), 7.59 (t, J=7.2 Hz, 1H), 7.28 (t, J=8.0 Hz, 1H), 7.22 (d, J=7.6 Hz, 1H), 7.13 (d, J=7.6 Hz, 1H), 3.87 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10716,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=7.2 Hz, 1H), 7.93 (d, J=8.4 Hz, 1H), 7.63 (t, J=8.4 Hz, 3H), 7.19 (dd, J=7.6, 5.2 Hz, 3H), 6.85 (s, 1H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.36 (s, 3H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10719,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.75-7.70 (m, 2H), 7.23 (d, J=7.6 Hz, 1H), 7.07 (s, 1H), 7.01-6.91 (m, 1H), 6.87 (dd, J=11.6, 5.2 Hz, 1H), 6.75 (d, J=7.6 Hz, 1H), 3.92 (q, J=7.2 Hz, 2H), 1.33 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10722,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J=8.0 Hz, 1H), 8.09 (d, J=6.8 Hz, 1H), 7.79 (t, J=7.2 Hz, 1H), 7.53 (d, J=7.2 Hz, 1H), 6.99 (s, 1H), 6.88 (d, J=7.2 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 3.30-2.79 (m, 2H), 1.91 (dd, J=14.8, 7.2 Hz, 2H), 1.37 (t, J=6.8 Hz, 3H), 1.02 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10725,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J=8.0 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.77 (t, J=7.2 Hz, 1H), 7.58 (d, J=7.2 Hz, 1H), 7.16 (s, 1H), 6.86 (d, J=7.2 Hz, 1H), 3.96 (q, J=7.2 Hz, 2H), 3.51-3.46 (m, 1H), 2.13-2.03 (m, 4H), 1.95-1.78 (m, 4H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10728,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J=6.8 Hz, 1H), 7.96-7.73 (m, 3H), 7.68-7.62 (m, 3H), 7.18 (d, J=7.6 Hz, 1H), 6.88 (s, 1H), 6.79 (d, J=7.2 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10731,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.49 (s, 1H), 8.14 (d, J=9.6 Hz, 2H), 8.00 (d, J=7.2 Hz, 2H), 7.93 (d, J=7.6 Hz, 1H), 7.77 (t, J=7.6 Hz, 1H), 7.69 (t, J=7.6 Hz, 1H), 7.13 (s, 2H), 3.87 (d, J=7.2 Hz, 2H), 3.17 (s, 3H), 1.23 (t, J=6.8 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10734,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.61 (s, 1H), 8.80 (d, J=8.4 Hz, 1H), 8.15 (d, J=8.0 Hz, 1H), 8.04 (d, J=7.6 Hz, 1H), 7.98 (d, J=7.2 Hz, 1H), 7.92 (t, J=7.6 Hz, 2H), 7.72-7.65 (m, 2H), 7.53-7.49 (m, 2H), 7.09 (d, J=7.6 Hz, 1H), 7.02 (d, J=7.6 Hz, 1H), 3.82 (q, J=7.2 Hz, 2H), 1.18 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10737,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.46 (s, 1H), 8.04 (d, J=8.4 Hz, 3H), 8.00 (d, J=7.2 Hz, 1H), 7.80 (d, J=8.4 Hz, 2H), 7.70 (t, J=7.6 Hz, 1H), 7.11 (s, 2H), 3.87 (q, J=7.2 Hz, 5H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10740,"The synthesis can refer to Example 7. 1H NMR (400 MHz, d-DMSO) δ 13.41 (s, 1H), 10.44 (s, 1H), 8.17-7.92 (m, 4H), 7.77 (d, J=8.0 Hz, 2H), 7.70 (t, J=7.6 Hz, 1H), 7.11 (s, 2H), 3.86 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10749,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.14 (s, 1H), 8.10 (d, J=8.4 Hz, 1H), 8.01 (d, J=6.8 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.26-7.00 (m, 4H), 6.91 (d, J=8.4 Hz, 1H), 4.25 (d, J=9.2 Hz, 4H), 3.87 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10752,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.87 (d, J=7.6 Hz, 1H), 7.80 (d, J=7.6 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.40 (t, J=7.6 Hz, 1H), 7.36-7.28 (m, 2H), 7.11 (d, J=7.6 Hz, 1H), 6.69 (d, J=7.6 Hz, 1H), 3.90 (q, J=7.2 Hz, 2H), 1.31 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10755,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.29 (s, 1H), 8.24 (d, J=8.4 Hz, 1H), 8.02 (d, J=6.8 Hz, 1H), 7.79 (t, J=7.6 Hz, 1H), 7.71 (d, J=8.8 Hz, 1H), 7.61 (s, 1H), 7.24 (d, J=7.6 Hz, 1H), 7.15 (d, J=8.8 Hz, 1H), 7.10 (d, J=7.6 Hz, 1H), 3.98-3.57 (m, 5H), 1.22 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10758,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J=8.0 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.50 (s, 1H), 7.45 (d, J=8.0 Hz, 2H), 7.38-7.29 (m, 1H), 7.22 (d, J=7.6 Hz, 1H), 6.74 (d, J=7.6 Hz, 1H), 3.92 (q, J=7.2 Hz, 2H), 1.33 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10761,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J=8.4 Hz, 1H), 8.04 (d, J=7.2 Hz, 1H), 7.72 (t, J=7.6 Hz, 1H), 7.27 (d, J=4.4 Hz, 1H), 7.22 (s, 1H), 7.11 (d, J=7.6 Hz, 1H), 7.02 (s, 2H), 6.70 (d, J=7.6 Hz, 1H), 4.07 (s, 3H), 3.90 (q, J=7.2 Hz, 2H), 3.67 (s, 3H), 1.31 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10764,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.52 (s, 1H), 8.05 (t, J=8.0 Hz, 2H), 7.93 (s, 1H), 7.76 (t, J=7.6 Hz, 1H), 7.60 (s, 2H), 7.29-6.97 (m, 2H), 3.88 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10767,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.77 (s, 1H), 8.24 (d, J=8.0 Hz, 1H), 8.03 (d, J=6.8 Hz, 1H), 7.89 (d, J=8.0 Hz, 1H), 7.80 (dd, J=7.6, 4.0 Hz, 2H), 7.42 (t, J=8.0 Hz, 1H), 7.18 (d, J=7.6 Hz, 1H), 7.09 (d, J=7.6 Hz, 1H), 3.85 (q, J=7.2 Hz, 2H), 1.21 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10770,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=6.8 Hz, 1H), 7.95 (t, J=8.4 Hz, 3H), 7.74 (t, J=7.6 Hz, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.36 (d, J=8.0 Hz, 2H), 6.87 (d, J=7.6 Hz, 1H), 6.82 (s, 1H), 4.43 (s, 2H), 3.97 (q, J=7.2 Hz, 2H), 3.91 (s, 3H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10773,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 12.92 (s, 1H), 9.96 (s, 1H), 8.31 (d, J=8.4 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.86-7.80 (m, 3H), 7.48 (d, J=7.6 Hz, 1H), 7.43 (d, J=8.0 Hz, 2H), 7.19 (d, J=7.6 Hz, 1H), 4.59 (s, 2H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10776,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=7.2 Hz, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.74 (t, J=7.6 Hz, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.32-7.13 (m, 2H), 7.04 (t, J=10.4 Hz, 3H), 6.91-6.66 (m, 2H), 4.37 (s, 2H), 3.98 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10779,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.94 (s, 1H), 8.27 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.88 (d, J=7.8 Hz, 1H), 7.86-7.82 (m, 2H), 7.60 (d, J=7.6 Hz, 1H), 7.51-7.35 (m, 2H), 7.17 (d, J=7.6 Hz, 1H), 4.61 (s, 2H), 3.92 (d, J=7.2 Hz, 2H), 3.79 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10782,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J=6.8 Hz, 1H), 7.97 (d, J=8.0 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.51 (t, J=6.4 Hz, 3H), 7.40 (d, J=7.6 Hz, 2H), 6.94 (s, 1H), 6.86 (d, J=7.6 Hz, 1H), 4.44 (s, 2H), 3.97 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10785,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.84 (s, 1H), 8.32 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.47 (d, J=7.6 Hz, 1H), 7.20-7.18 (m, 3H), 7.11 (d, J=7.6 Hz, 2H), 4.42 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 2.28 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10788,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.03 (s, 1H), 8.34 (d, J=8.4 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 7.50 (d, J=7.6 Hz, 1H), 7.41 (t, J=7.2 Hz, 2H), 7.20-7.16 (m, 3H), 4.53 (s, 2H), 3.93 (q, J=7.2 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10791,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.92 (s, 1H), 8.31 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.48 (d, J=7.6 Hz, 1H), 7.35 (q, J=8.4 Hz, 4H), 7.18 (d, J=7.6 Hz, 1H), 4.51 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10794,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 10.01 (s, 1H), 8.29 (d, J=8.0 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.78 (d, J=8.0 Hz, 2H), 7.52-7.46 (m, 3H), 7.19 (d, J=7.6 Hz, 1H), 4.64 (s, 2H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10797,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=7.2 Hz, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.84-7.68 (m, 1H), 7.51 (d, J=7.6 Hz, 1H), 7.25 (d, J=9.2 Hz, 1H), 6.98 (t, J=8.4 Hz, 2H), 6.87 (d, J=7.6 Hz, 1H), 6.71 (s, 1H), 4.36 (s, 2H), 3.98 (q, J=7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10805,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.23 (s, 1H), 8.28 (d, J=8.0 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.76 (d, J=7.6 Hz, 1H), 7.61-7.26 (m, 4H), 7.16 (d, J=7.6 Hz, 1H), 3.90 (q, J=7.2 Hz, 2H), 3.82 (s, 2H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10808,"The synthesis can refer to Example 46. 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J=6.8 Hz, 1H), 7.87 (d, J=7.6 Hz, 1H), 7.62 (t, J=7.6 Hz, 1H), 7.55 (s, 1H), 7.50 (d, J=8.0 Hz, 1H), 6.98-6.94 (m, 3H), 6.85 (d, J=7.6 Hz, 1H), 3.96-3.92 (m, 8H), 3.82 (s, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10811,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.29 (s, 1H), 8.33 (d, J=8.0 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 7.74 (d, J=7.6 Hz, 1H), 7.63 (s, 1H), 7.52 (d, J=8.4 Hz, 1H), 7.43 (d, J=8.4 Hz, 1H), 7.17 (d, J=7.6 Hz, 1H), 4.01 (s, 2H), 3.91 (q, J=7.2 Hz, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10817,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.14 (s, 1H), 8.32 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.77 (d, J=7.6 Hz, 1H), 7.18 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 2.88-2.71 (m, 2H), 2.71-2.51 (m, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10820,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 9.92 (s, 1H), 8.30 (d, J=8.4 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.89-7.62 (m, 2H), 7.16 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 2.46 (q, J=7.6 Hz, 2H), 1.26 (t, J=7.2 Hz, 3H), 1.16 (t, J=7.6 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10823,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.55 (s, 1H), 8.20 (d, J=8.0 Hz, 1H), 8.09 (t, J=8.8 Hz, 3H), 7.81 (t, J=7.6 Hz, 1H), 7.65 (d, J=8.4 Hz, 3H), 7.23 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.29 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10826,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) d 10.19 (s, 1H), 8.27 (d, J=8.0 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.75 (d, J=7.6 Hz, 1H), 7.30 (d, J=7.6 Hz, 2H), 7.16 (d, J=7.6 Hz, 3H), 3.90 (q, J=7.2 Hz, 2H), 3.75 (s, 2H), 2.29 (s, 3H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10829,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.24 (s, 1H), 8.43 (d, J=8.0 Hz, 1H), 8.07 (t, J=7.6 Hz, 2H), 7.84 (d, J=11.2 Hz, 2H), 7.45 (d, J=11.2 Hz, 1H), 7.20 (d, J=7.6 Hz, 1H), 7.04-6.75 (m, 2H), 6.64 (s, 1H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10837,"The synthesis can refer to Example 56. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=7.6 Hz, 2H), 7.66 (t, J=7.6 Hz, 1H), 6.79 (d, J=7.6 Hz, 1H), 6.35 (d, J=7.6 Hz, 1H), 5.81 (s, 1H), 3.95 (q, J=7.2 Hz, 2H), 3.82 (t, J=4.4 Hz, 4H), 3.35 (t, J=6.0 Hz, 2H), 2.60-2.54 (m, 6H), 2.02-1.87 (m, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10840,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.51 (d, J=8.0 Hz, 1H), 7.98 (d, J=7.2 Hz, 1H), 7.71 (t, J=7.6 Hz, 1H), 7.33 (d, J=8.4 Hz, 2H), 7.05 (s, 1H), 6.88 (d, J=8.4 Hz, 3H), 6.21 (d, J=7.6 Hz, 1H), 4.40 (d, J=4.4 Hz, 2H), 3.82 (q, J=7.2 Hz, 2H), 3.70 (d, J=8.8 Hz, 3H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10843,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.52 (d, J=8.0 Hz, 1H), 7.99 (d, J=6.8 Hz, 1H), 7.71 (t, J=7.6 Hz, 1H), 7.29 (d, J=7.6 Hz, 2H), 7.12 (d, J=7.6 Hz, 3H), 6.87 (d, J=7.6 Hz, 1H), 6.17 (d, J=7.6 Hz, 1H), 4.42 (s, 2H), 3.81 (q, J=7.2 Hz, 2H), 2.26 (s, 3H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10846,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.52 (d, J=8.0 Hz, 1H), 8.00 (d, J=6.8 Hz, 1H), 7.74 (t, J=7.6 Hz, 1H), 7.69 (d, J=8.0 Hz, 2H), 7.63 (d, J=8.0 Hz, 2H), 7.26 (s, 1H), 6.87 (d, J=7.6 Hz, 1H), 6.14 (d, J=7.6 Hz, 1H), 4.58 (d, J=5.2 Hz, 2H), 3.81 (q, J=7.2 Hz, 2H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10849,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.51 (d, J=8.4 Hz, 1H), 8.00 (d, J=6.8 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.43 (d, J=8.4 Hz, 2H), 7.37 (d, J=8.4 Hz, 2H), 7.18 (t, J=6.0 Hz, 1H), 6.88 (d, J=7.6 Hz, 1H), 6.15 (d, J=7.6 Hz, 1H), 4.47 (d, J=6.0 Hz, 2H), 3.82 (q, J=7.2 Hz, 2H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10852,"The synthesis can refer to Example 56. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=7.2 Hz, 1H), 8.00 (d, J=8.2 Hz, 1H), 7.66 (t, J=7.6 Hz, 1H), 7.41 (dd, J=8.4, 5.6 Hz, 2H), 7.06 (t, J=8.4 Hz, 2H), 6.75 (d, J=7.6 Hz, 1H), 6.38 (d, J=7.6 Hz, 1H), 4.66 (s, 1H), 4.45 (s, 2H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10854,"Example 63: Synthesis of N-((1-acetylpiperidin-4-yl)methyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",0,data/dev/US20180008574A1.txt,1
10855,"<img> id-US20180008574A1-20180111-C00080.TIF </img>
",0,data/dev/US20180008574A1.txt,1
10856,"The synthesis of 1-ethylbenzo[cd]indol-2(1H)-one can refer to Example 1.
",0,data/dev/US20180008574A1.txt,1
10863,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) d 8.58 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.09 (d, J=7.6 Hz, 1H), 7.96 (t, J=8.0 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.92 (q, J=6.8 Hz, 2H), 3.26-3.21 (m, 4H), 1.25 (t, J=7.2 Hz, 3H), 1.01-0.98 (m, 6H). MS (ESI), m/z: M− 400.8.
",1,data/dev/US20180008574A1.txt,0
10879,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.64 (d, J=8.4 Hz, 1H), 8.41 (s, 1H), 8.12 (d, J=6.8 Hz, 1H), 8.03 (d, J=8.0 Hz, 1H), 7.91 (t, J=7.2 Hz, 1H), 7.21 (d, J=7.6 Hz, 1H), 7.15 (t, J=8.0 Hz, H), 7.07-7.05 (m, 1H), 7.91-7.83 (m, 2H), 4.06 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 1.29 (t, J=7.2 Hz, 3H). MS (ESI), m/z: M− 383.0.
",1,data/dev/US20180008574A1.txt,0
10888,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.72 (d, J=8.4 Hz, 1H), 8.14 (d, J=6.8 Hz, 1H), 8.09 (d, J=7.6 Hz, H), 7.95 (t, J=7.6 Hz, 1H), 7.80 (d, J=7.2 Hz, 1H), 7.26 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 3.44 (q, J=6.4 Hz, 1H), 1.51-1.46 (m, 4H), 1.28-1.22 (m, 7H). MS (ESI), m/z: M 343.0.
",1,data/dev/US20180008574A1.txt,0
10901,"The synthesis can refer to Example 74. 1H NMR (400 MHz, d-DMSO) δ 11.96 (s, 1H), 8.52 (d, J=8.4 Hz, 1H), 8.26 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 8.02-7.84 (m, 1H), 7.80 (d, J=7.2 Hz, 1H), 7.63-7.41 (m, 2H), 7.28 (d, J=7.6 Hz, 1H), 7.02 (t, J=7.6 Hz, 1H), 3.89 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10904,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.48 (s, 1H), 8.64 (d, J=8.4 Hz, 1H), 8.13-8.07 (m, 2H), 8.00-7.79 (m, 1H), 7.25 (d, J=7.6 Hz, 1H), 7.17-6.83 (m, 4H), 3.89 (q, J=7.2 Hz, 2H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10907,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 8.01-7.85 (m, 1H), 7.77 (t, J=6.0 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.75 (dd, J=13.2, 6.8 Hz, 2H), 1.35-1.21 (m, 5H), 1.19-1.12 (m, 2H), 0.70 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10910,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.65 (d, J=8.2 Hz, 1H), 8.14 (d, J=6.4 Hz, 1H), 8.06 (d, J=7.2 Hz, 1H), 7.94 (t, J=7.2 Hz, 1H), 7.87 (s, 1H), 7.76 (s, 1H), 7.30 (d, J=7.2 Hz, 1H), 3.93 (d, J=6.8 Hz, 2H), 3.01 (d, J=5.6 Hz, 2H), 2.77 (s, 2H), 1.65 (s, 3H), 1.26 (t, J=6.4 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10913,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.64 (d, J=8.4 Hz, 1H), 8.16-8.10 (m, 3H), 7.96 (t, J=7.6 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 3.94 (q, J=6.8 Hz, 2H), 3.23 (t, J=6.8 Hz, 2H), 3.14 (t, J=6.8 Hz, 2H), 2.97 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10916,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.66 (d, J=8.0 Hz, 1H), 8.14 (d, J=6.4 Hz, 1H), 8.08 (d, J=7.2 Hz, 1H), 7.92 (d, J=6.4 Hz, 2H), 7.29 (d, J=7.2 Hz, 1H), 6.23 (s, 1H), 3.93 (d, J=6.4 Hz, 2H), 3.18 (d, J=7.2 Hz, 2H), 3.09-3.02 (m, 4H), 2.86-2.84 (m, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10919,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.67 (d, J=8.4 Hz, 1H), 8.13 (d, J=6.8 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.93 (t, J=7.6 Hz, 1H), 7.76 (s, 1H), 7.29 (d, J=7.6 Hz, 1H), 6.67 (s, 1H), 3.92 (d, J=7.2 Hz, 2H), 2.91-2.64 (m, 4H), 1.26 (s, 9H), 1.25-1.24 (m, 4H), 1.24 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10922,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.48 (s, 1H), 10.34 (s, 1H), 8.62 (d, J=8.4 Hz, 1H), 8.12 (d, J=7.6 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.99-7.70 (m, 3H), 7.41 (d, J=8.8 Hz, 1H), 7.23 (d, J=7.6 Hz, 1H), 3.88 (q, J=6.8 Hz, 2H), 1.98 (d, J=8.4 Hz, 3H), 1.22 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10925,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=8.4 Hz, 1H), 8.23 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 7.85 (t, J=7.6 Hz, 1H), 6.95 (d, J=7.6 Hz, 1H), 5.10 (d, J=7.2 Hz, 1H), 4.00 (q, J=7.2 Hz, 2H), 3.86 (d, J=4.8 Hz, 1H), 3.48-3.30 (m, 2H), 3.29-3.26 (m, 1H), 3.07-3.03 (m, 1H), 1.94-1.87 (m, 2H), 1.48-1.29 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
10928,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.12 (d, J=6.8 Hz, 1H) 7.85 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 5.31 (d, J=8.8 Hz, 1H), 4.11 (d, J=8.0 Hz, 1H), 4.01-3.95 (m, 4H), 3.56 (s, 2H), 1.44-1.30 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
10931,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.2 Hz, 1H), 6.93 (d, J=7.5 Hz, 1H), 4.41 (t, J=6.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.97 (dd, J=13.2, 6.8 Hz, 2H), 1.39-1.37 (m, 4H), 1.28-1.25 (m, 6H), 1.13-1.08 (m, 2H), 1.02-0.97 (m, 2H), 0.96-0.89 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10934,"The synthesis of tert-butyl3-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido) pyrrolidine-1-carboxylate can refer to 84.
",1,data/dev/US20180008574A1.txt,0
10938,"The synthesis can refer to Example 87. 1H NMR (400 MHz, d-DMSO) δ 8.78 (d, J=7.6 Hz, 1H), 8.61 (d, J=8.4 Hz, 2H), 8.18 (d, J=7.2 Hz, 1H), 8.10 (d, J=7.6 Hz, 1H), 7.99 (t, 7.2 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 3.86 (t, J=9.2 Hz, 2H), 3.66 (s, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10941,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.2 Hz, 1H), 8.07 (d, J=7.6 Hz, 1H), 8.00-7.83 (m, 1H), 7.76 (t, J=6.0 Hz, 1H), 7.29 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.75 (dd, J=12.8, 6.4 Hz, 2H), 1.35-1.12 (m, 6H), 1.09-0.88 (m, 6H), 0.67 (t, J=6.8 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10944,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.2 Hz, 1H), 8.17 (d, J=6.8 Hz, 1H), 8.12 (d, J=7.6 Hz, 1H), 7.96 (t, J=7.6 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 4.00-3.88 (m, 2H), 3.18-3.02 (m, 3H), 2.85 (s, 4H), 1.73 (s, 3H), 1.28 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10947,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 7.96 (t, J=7.6 Hz, 1H), 7.78 (s, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.93 (t, J=7.2 Hz, 2H), 3.63 (dd, J=11.2, 3.6 Hz, 2H), 2.89 (t, J=11.2 Hz, 2H), 2.80 (d, J=4.8 Hz, 2H), 1.35-1.10 (m, 8H), 0.90-0.86 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10950,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=6.0 Hz, 2H), 8.11 (d, J=7.6 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.32 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 3.72 (s, 1H), 3.64 (dd, J=14.4, 7.2 Hz, 1H), 3.59-3.44 (m, 2H), 1.81-1.76 (m, 1H), 1.53 (dd, J=12.4, 6.0 Hz, 1H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10953,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.09 (d, J=7.2 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.10 (d, J=8.8 Hz, 2H), 6.88 (d, J=7.6 Hz, 1H), 6.51 (d, J=8.8 Hz, 2H), 5.08 (t, J=6.0 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 3.88 (t, J=5.2 Hz, 2H), 3.37 (dd, J=10.8, 5.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10956,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J=8.4 Hz, 1H), 8.20 (d, J=7.6 Hz, 1H), 8.12 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.93 (d, J=7.6 Hz, 1H), 4.52 (s, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.02 (t, J=7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 1.08 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10959,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.54 (d, J=6.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.94 (q, J=6.8 Hz, 2H), 1.40 (q, J=7.2 Hz, 5H), 1.16 (d, J=6.4 Hz, 4H), 0.75 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10962,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 6.94 (d, J=7.6 Hz, 1H), 4.49 (d, J=5.2 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.65 (d, J=5.2 Hz, 3H), 1.39 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10965,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.20 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.2 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.52 (d, J=7.6 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.29-2.92 (m, 1H), 1.75-1.63 (m, 2H), 1.58-1.50 (m, 1H), 1.49-1.46 (m, 1H), 1.40 (t, J=7.2 Hz, 3H), 1.25-1.05 (m, 6H).
",1,data/dev/US20180008574A1.txt,0
10968,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.87 (s, 1H), 3.98 (q, J=7.2 Hz, 2H), 3.47-3.16 (m, 4H), 3.02 (dd, J=13.2, 7.2 Hz, 1H), 1.67-1.53 (m, 2H), 1.47-1.25 (m, 14H).
",1,data/dev/US20180008574A1.txt,0
10971,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.61 (t, J=6.4 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.75 (t, J=6.4 Hz, 2H), 1.67 (dt, J=13.2, 6.8 Hz, 1H), 1.39 (t, J=7.2 Hz, 3H), 0.81 (d, J=6.8 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10974,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.92-7.68 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.66 (t, J=6.0 Hz, 1H), 3.98 (q, J=7.2 Hz, 2H), 2.91 (dd, J=13.2, 6.8 Hz, 2H), 1.46 (dt, J=14.4, 7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 0.80 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10977,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.16 (d, J=6.8 Hz, 1H), 8.08 (d, J=7.2 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.78 (s, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.79 (d, J=5.6 Hz, 2H), 2.23-1.86 (m, 11H), 1.48-1.33 (m, 2H), 1.28 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10980,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.15 (d, J=6.8 Hz, 1H), 8.10 (d, J=7.6 Hz, 1H), 7.94 (t, J=7.6 Hz, 1H), 7.67 (s, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.88 (t, J=6.4 Hz, 2H), 2.23-2.11 (m, 2H), 2.10-2.01 (m, 3H), 1.30-1.22 (m, 7H), 0.94-0.65 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10983,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.67 (d, J=8.4 Hz, 1H), 8.14 (d, J=6.8 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.93 (t, J=7.6 Hz, 1H), 7.79 (t, J=5.2 Hz, 1H), 7.29 (d, J=7.6 Hz, 1H), 4.18 (s, 1H), 3.92 (q, J=6.8 Hz, 2H), 3.42-3.31 (m, 2H), 3.23-3.17 (m, 2H), 2.78 (d, J=5.2 Hz, 2H), 1.35-1.21 (m, 7H), 0.95 (t, J=6.8 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10986,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.96-7.69 (m, 1H), 6.93 (d, J=7.6 Hz, 1H), 5.35 (t, J=6.4 Hz, 1H), 4.01-3.96 (m, 4H), 3.19 (dd, J=12.4, 6.4 Hz, 2H), 2.48 (t, J=6.0 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 1.18 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10989,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.68 (d, J=8.4 Hz, 1H), 8.12 (dd, J=10.4, 7.2 Hz, 2H), 7.96-7.78 (m, 1H), 6.90 (d, J=7.6 Hz, 1H), 3.98 (q, J=7.2 Hz, 2H), 3.67 (d, J=5.6 Hz, 1H), 3.46 (s, 1H), 3.37 (dd, J=14.4, 7.6 Hz, 2H), 3.19 (dd, J=14.4, 3.2 Hz, 1H), 2.87 (s, 1H), 2.76 (s, 1H), 2.15-1.80 (m, 5H), 1.38 (t, J=7.2 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10992,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.2 Hz, 1H), 8.09 (d, J=7.6 Hz, 1H), 7.93 (dd, J=12.4, 5.6 Hz, 2H), 7.29 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.93 (s, 1H), 2.58 (d, J=11.2 Hz, 2H), 2.06 (s, 3H), 1.82 (s, 2H), 1.44 (d, J=10.4 Hz, 2H), 1.38-1.35 (m, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10995,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 7.93-7.60 (m, 1H), 6.94 (d, J=7.6 Hz, 1H), 4.55 (d, J=8.0 Hz, 1H), 4.01 (q, J=7.2 Hz, 2H), 3.50-3.20 (m, 1H), 1.73-1.69 (m, 2H), 1.55-0.99 (m, 15H).
",1,data/dev/US20180008574A1.txt,0
10998,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.93-7.77 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.65 (d, J=8.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.82 (d, J=12.0 Hz, 2H), 3.44-3.34 (m, 1H), 3.30 (t, J=10.8 Hz, 2H), 1.69 (d, J=13.2 Hz, 2H), 1.51-1.35 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11001,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.93-7.75 (m, 1H), 6.93 (d, J=7.6 Hz, 1H), 5.35 (s, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.28-3.10 (m, 4H), 2.98 (s, 2H), 2.41-2.23 (m, 2H), 2.16-2.04 (m, 4H), 1.47-1.30 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
11004,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.70 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 8.02-7.89 (m, 1H), 7.85 (d, J=7.6 Hz, 1H), 7.23 (d, J=7.6 Hz, 1H), 3.38 (s, 3H), 2.94 (s, 1H), 1.57-1.33 (m, 5H), 1.04-0.88 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11007,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 7.99-7.83 (m, 1H), 7.77 (s, 1H), 7.25 (d, J=7.6 Hz, 1H), 3.39 (s, 3H), 2.74 (d, J=3.2 Hz, 2H), 1.27 (dd, J=14.8, 7.2 Hz, 2H), 1.15 (dd, J=14.8, 7.2 Hz, 2H), 0.70 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11010,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.2 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.83 (t, 7.2 Hz, 1H), 6.91 (d, J=7.6 Hz, 1H), 4.57 (d, J=7.6 Hz, 1H), 3.89 (t, J=7.2 Hz, 2H), 3.31-3.03 (m, 1H), 1.82 (dt, J=14.8, 7.2 Hz, 2H), 1.74-1.64 (m, 2H), 1.57-1.56 (m, 2H), 1.48 (d, J=12.4 Hz, 1H), 1.17-1.08 (m, 4H), 1.02 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11013,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.94-7.66 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.60 (t, J=6.0 Hz, 1H), 3.89 (t, J=7.2 Hz, 2H), 2.92 (d d, J=13.6, 6.8 Hz, 2H), 1.78 (dt, J=14.4, 7.2 Hz, 2H), 1.44 (dt, J=14.4, 7.2 Hz, 2H), 1.01 (t, J=7.2 Hz, 3H), 0.81 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11016,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.84 (dd, J=8.2, 7.2 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.51 (t, J=6.0 Hz, 1H), 3.90 (t, J=7.2 Hz, 2H), 2.94 (dd, J=13.2, 6.8 Hz, 2H), 1.88-1.70 (m, 2H), 1.50-1.33 (m, 2H), 1.23 (dt, J=14.4, 7.2 Hz, 3H), 1.01 (t, J=7.2 Hz, 3H), 0.78 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11019,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 11.13 (s, 1H), 8.68 (d, J=8.4 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 8.03 (d, J=7.6 Hz, 1H), 7.98-7.87 (m, 1H), 7.74 (t, J=5.6 Hz, 1H), 7.06 (d, J=7.6 Hz, 1H), 2.74 (dd, J=13.2, 6.8 Hz, 2H), 1.35-1.19 (m, 2H), 1.19-0.98 (m, 2H), 0.69 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11022,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.2 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 8.03-7.83 (m, 1H), 7.77 (t, J=6.0 Hz, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.72 (d, J=7.2 Hz, 2H), 2.76 (dd, J=12.8, 6.8 Hz, 2H), 2.15 (dt, J=13.2, 6.8 Hz, 1H), 1.37-1.21 (m, 2H), 1.18-1.10 (m, 2H), 0.93 (s, 3H), 0.91 (s, 3H), 0.68 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11025,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) 8.70 (d, J=8.4 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 8.08-7.93 (m, 1H), 7.85 (t, J=6.0 Hz, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.71 (d, J=7.2 Hz, 2H), 2.94 (s, 1H), 2.08-1.96 (m, 1H), 1.47-1.36 (m, 5H), 1.05-0.90 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11028,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 11.10 (s, 1H), 8.69 (d, J=8.4 Hz, 1H), 8.09 (d, J=6.8 Hz, 1H), 8.04 (d, J=7.6 Hz, 1H), 7.96-7.87 (m, 1H), 7.81 (d, J=7.6 Hz, 1H), 7.04 (d, J=7.6 Hz, 1H), 2.93 (s, 1H), 1.58-1.30 (m, 5H), 1.06-0.98 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11031,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.82 (s, 1H), 8.70 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.13 (d, J=6.8 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.65-7.46 (m, 2H), 7.39-7.24 (m, 3H), 3.88 (q, J=6.8 Hz, 2H), 2.45 (s, 3H), 1.22 (t, J=7.2 Hz, 3H). 13C NMR (500 MHz, d-DMSO) δ 197.1, 166.6, 143.4, 138.0, 137.5, 133.5, 130.7, 129.6, 128.9, 127.4, 126.0, 125.2, 124.8, 123.9, 123.8, 123.2, 117.7, 103.9, 34.6, 26.5, 13.5.
",1,data/dev/US20180008574A1.txt,0
11034,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.54 (d, J=8.4 Hz, 1H), 8.09 (d, J=7.6 Hz, 2H), 7.79 (t, J=7.6 Hz, 1H), 7.13 (d, J=8.4 Hz, 2H), 6.94 (d, J=8.4 Hz, 2H), 6.90 (s, 1H), 6.85 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11037,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.56 (s, 1H), 8.69 (d, J=8.4 Hz, 1H), 8.16-8.11 (m, 2H), 7.93 (t, J=7.6 Hz, 1H), 7.26 (d, J=7.6 Hz, 1H), 7.16 (t, J=7.6 Hz, 2H), 7.04 (d, J=7.6 Hz, 2H), 6.94 (t, J=7.2 Hz, 1H), 3.89 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11040,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.07 (d, J=7.2 Hz, 1H), 7.77 (t, J=7.6 Hz, 1H), 7.66 (d, J=8.4 Hz, 1H), 7.22 (t, J=7.6 Hz, 1H), 7.13 (d, J=7.6 Hz, 2H), 6.99 (t, J=7.6 Hz, 1H), 6.84 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11043,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.55 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.6 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.80 (t, J=7.6 Hz, 1H), 7.16-7.01 (m, 3H), 6.93-6.82 (m, 2H), 3.96 (d, J=7.2 Hz, 2H), 1.37 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11044,"Example 124
",0,data/dev/US20180008574A1.txt,1
11052,"Example 125
",0,data/dev/US20180008574A1.txt,1
11388,"<img> id-US20180016269A1-20180118-C00020.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11390,"<img> id-US20180016269A1-20180118-C00021.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11392,"<img> id-US20180016269A1-20180118-C00022.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11394,"<img> id-US20180016269A1-20180118-C00023.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11396,"<img> id-US20180016269A1-20180118-C00024.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11398,"<img> id-US20180016269A1-20180118-C00025.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11400,"<img> id-US20180016269A1-20180118-C00026.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11402,"<img> id-US20180016269A1-20180118-C00027.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11404,"<img> id-US20180016269A1-20180118-C00028.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11406,"<img> id-US20180016269A1-20180118-C00029.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11408,"<img> id-US20180016269A1-20180118-C00030.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11410,"<img> id-US20180016269A1-20180118-C00031.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11412,"<img> id-US20180016269A1-20180118-C00032.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11414,"<img> id-US20180016269A1-20180118-C00033.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11416,"<img> id-US20180016269A1-20180118-C00034.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11418,"<img> id-US20180016269A1-20180118-C00035.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11420,"<img> id-US20180016269A1-20180118-C00036.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11422,"<img> id-US20180016269A1-20180118-C00037.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11424,"<img> id-US20180016269A1-20180118-C00038.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11426,"<img> id-US20180016269A1-20180118-C00039.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11428,"<img> id-US20180016269A1-20180118-C00040.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11430,"<img> id-US20180016269A1-20180118-C00041.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11432,"<img> id-US20180016269A1-20180118-C00042.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11434,"<img> id-US20180016269A1-20180118-C00043.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11436,"<img> id-US20180016269A1-20180118-C00044.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11438,"<img> id-US20180016269A1-20180118-C00045.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11440,"<img> id-US20180016269A1-20180118-C00046.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11442,"<img> id-US20180016269A1-20180118-C00047.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11444,"<img> id-US20180016269A1-20180118-C00048.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11446,"<img> id-US20180016269A1-20180118-C00049.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11448,"<img> id-US20180016269A1-20180118-C00050.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11450,"<img> id-US20180016269A1-20180118-C00051.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11452,"<img> id-US20180016269A1-20180118-C00052.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11454,"<img> id-US20180016269A1-20180118-C00053.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11456,"<img> id-US20180016269A1-20180118-C00054.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11458,"<img> id-US20180016269A1-20180118-C00055.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11460,"<img> id-US20180016269A1-20180118-C00056.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11462,"<img> id-US20180016269A1-20180118-C00057.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11464,"<img> id-US20180016269A1-20180118-C00058.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11466,"<img> id-US20180016269A1-20180118-C00059.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11468,"<img> id-US20180016269A1-20180118-C00060.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11470,"<img> id-US20180016269A1-20180118-C00061.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11472,"<img> id-US20180016269A1-20180118-C00062.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11474,"<img> id-US20180016269A1-20180118-C00063.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11476,"<img> id-US20180016269A1-20180118-C00064.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11478,"<img> id-US20180016269A1-20180118-C00065.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11480,"<img> id-US20180016269A1-20180118-C00066.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11482,"<img> id-US20180016269A1-20180118-C00067.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11484,"<img> id-US20180016269A1-20180118-C00068.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11486,"<img> id-US20180016269A1-20180118-C00069.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11488,"<img> id-US20180016269A1-20180118-C00070.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11490,"<img> id-US20180016269A1-20180118-C00071.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11492,"<img> id-US20180016269A1-20180118-C00072.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11494,"<img> id-US20180016269A1-20180118-C00073.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11496,"<img> id-US20180016269A1-20180118-C00074.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11498,"<img> id-US20180016269A1-20180118-C00075.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11500,"<img> id-US20180016269A1-20180118-C00076.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11502,"<img> id-US20180016269A1-20180118-C00077.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11504,"<img> id-US20180016269A1-20180118-C00078.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11506,"<img> id-US20180016269A1-20180118-C00079.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11508,"<img> id-US20180016269A1-20180118-C00080.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11517,"<img> id-US20180016269A1-20180118-C00081.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11530,"<img> id-US20180016269A1-20180118-C00082.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11532,"<img> id-US20180016269A1-20180118-C00083.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11534,"<img> id-US20180016269A1-20180118-C00084.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11536,"<img> id-US20180016269A1-20180118-C00085.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11538,"<img> id-US20180016269A1-20180118-C00086.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11540,"<img> id-US20180016269A1-20180118-C00087.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11542,"<img> id-US20180016269A1-20180118-C00088.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11544,"<img> id-US20180016269A1-20180118-C00089.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11546,"<img> id-US20180016269A1-20180118-C00090.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11548,"<img> id-US20180016269A1-20180118-C00091.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11550,"<img> id-US20180016269A1-20180118-C00092.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11552,"<img> id-US20180016269A1-20180118-C00093.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11554,"<img> id-US20180016269A1-20180118-C00094.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11556,"<img> id-US20180016269A1-20180118-C00095.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11558,"<img> id-US20180016269A1-20180118-C00096.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11560,"<img> id-US20180016269A1-20180118-C00097.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11562,"<img> id-US20180016269A1-20180118-C00098.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11564,"<img> id-US20180016269A1-20180118-C00099.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11566,"<img> id-US20180016269A1-20180118-C00100.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11568,"<img> id-US20180016269A1-20180118-C00101.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11570,"<img> id-US20180016269A1-20180118-C00102.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11572,"<img> id-US20180016269A1-20180118-C00103.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11574,"<img> id-US20180016269A1-20180118-C00104.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11576,"<img> id-US20180016269A1-20180118-C00105.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11578,"<img> id-US20180016269A1-20180118-C00106.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11580,"<img> id-US20180016269A1-20180118-C00107.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11582,"<img> id-US20180016269A1-20180118-C00108.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11584,"<img> id-US20180016269A1-20180118-C00109.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11586,"<img> id-US20180016269A1-20180118-C00110.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11588,"<img> id-US20180016269A1-20180118-C00111.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11590,"<img> id-US20180016269A1-20180118-C00112.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11592,"<img> id-US20180016269A1-20180118-C00113.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11594,"<img> id-US20180016269A1-20180118-C00114.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11596,"<img> id-US20180016269A1-20180118-C00115.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11598,"<img> id-US20180016269A1-20180118-C00116.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11600,"<img> id-US20180016269A1-20180118-C00117.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11602,"<img> id-US20180016269A1-20180118-C00118.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11604,"<img> id-US20180016269A1-20180118-C00119.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11606,"<img> id-US20180016269A1-20180118-C00120.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11608,"<img> id-US20180016269A1-20180118-C00121.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11610,"<img> id-US20180016269A1-20180118-C00122.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11612,"<img> id-US20180016269A1-20180118-C00123.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11614,"<img> id-US20180016269A1-20180118-C00124.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11616,"<img> id-US20180016269A1-20180118-C00125.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11618,"<img> id-US20180016269A1-20180118-C00126.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11620,"<img> id-US20180016269A1-20180118-C00127.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11622,"<img> id-US20180016269A1-20180118-C00128.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11624,"<img> id-US20180016269A1-20180118-C00129.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11626,"<img> id-US20180016269A1-20180118-C00130.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11628,"<img> id-US20180016269A1-20180118-C00131.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11630,"<img> id-US20180016269A1-20180118-C00132.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11632,"<img> id-US20180016269A1-20180118-C00133.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11634,"<img> id-US20180016269A1-20180118-C00134.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11636,"<img> id-US20180016269A1-20180118-C00135.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11665,"From: & (20 g) & (150 g) & (3.5 kg) & (8 kg) & (60 kg)
",0,data/dev/US20180016269A1.txt,1
11697,"5. DMF: N,N-dimethylformamide
",0,data/dev/US20180016269A1.txt,1
11715,"Example 1. Synthesis of (2S,4R)-1-((S)-2-(tert-butyl)-17-(4-((Z)-1,2-diphenylbut-1-en-1-yl)phenoxy)-15-methyl-4,14-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
",0,data/dev/US20180016269A1.txt,1
11716,"Intermediate 1
",1,data/dev/US20180016269A1.txt,0
11721,"Intermediate 2
",1,data/dev/US20180016269A1.txt,0
11725,"Example 1
",1,data/dev/US20180016269A1.txt,0
11729,"Example 2. Synthesis of N1-(2-(4-((Z)-1,2-diphenylbut-1-en-1-yl)phenoxy)ethyl)-N8-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N1-methyloctanediamide
",0,data/dev/US20180016269A1.txt,1
11730,"Intermediate 1
",1,data/dev/US20180016269A1.txt,0
11734,"Example 2
",1,data/dev/US20180016269A1.txt,0
11738,"Example 3. Synthesis of Exemplary Compounds
",1,data/dev/US20180016269A1.txt,0
11739,"General Procedure for Linker Coupling
",1,data/dev/US20180016269A1.txt,0
11766,"General Procedure for Linker Coupling
",1,data/dev/US20180016269A1.txt,0
11847,"Example 4. N1-(2-(4-((Z)-1,2-Diphenylbut-1-en-1-yl)phenoxy)ethyl)-N11-((S)-1-((2S,4R)-4-hydroxy-2-((4-(quinazolin-6-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N1-methylundecanediamide
",0,data/dev/US20180016269A1.txt,1
11848,"<img> id-US20180016269A1-20180118-C00177.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11859,"1 & <img> id-US20180016269A1-20180118-C00178.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11860,"2 & <img> id-US20180016269A1-20180118-C00179.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11862,"4 & <img> id-US20180016269A1-20180118-C00181.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11867,"<img> id-US20180016269A1-20180118-C00182.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11869,"<img> id-US20180016269A1-20180118-C00183.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11889,"<img> id-US20180016269A1-20180118-C00184.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11891,"<img> id-US20180016269A1-20180118-C00185.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11923,"<img> id-US20180016269A1-20180118-C00193.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11927,"<img> id-US20180016269A1-20180118-C00194.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11934,"<img> id-US20180016269A1-20180118-C00195.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11973,"<img> id-US20180016269A1-20180118-C00196.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11978,"<img> id-US20180016269A1-20180118-C00197.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11983,"<img> id-US20180016269A1-20180118-C00198.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11991,"<img> id-US20180016269A1-20180118-C00199.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12004,"<img> id-US20180016269A1-20180118-C00200.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12007,"<img> id-US20180016269A1-20180118-C00201.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12016,"<img> id-US20180016269A1-20180118-C00202.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12027,"<img> id-US20180016269A1-20180118-C00203.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12038,"<img> id-US20180016269A1-20180118-C00204.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12041,"<img> id-US20180016269A1-20180118-C00205.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12052,"<img> id-US20180016269A1-20180118-C00206.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12099,"<img> id-US20180016269A1-20180118-C00207.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12138,"<img> id-US20180016269A1-20180118-C00208.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12141,"<img> id-US20180016269A1-20180118-C00209.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12144,"<img> id-US20180016269A1-20180118-C00210.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12147,"<img> id-US20180016269A1-20180118-C00211.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12235,"Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside, 12
",1,data/dev/EP3305797A1.txt,0
12242,"Phenyl 1-thio-β-D-galactopyranoside, 14
",1,data/dev/EP3305797A1.txt,0
12248,"1.3. Preparation of 3,4-O-isopropylidene acetals.
",0,data/dev/EP3305797A1.txt,1
12249,"Phenil 3,4-O-isopropylidene-1-thio-β-D-galactopyranoside, 16.
",1,data/dev/EP3305797A1.txt,0
12255,"1.4. Selective protection of the primary hydroxyl.
",1,data/dev/EP3305797A1.txt,0
12256,"Phenyl 3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-1-thio-β-D-galactopyranoside, 18
",1,data/dev/EP3305797A1.txt,0
12260,"Phenyl 2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-1-thio-β-D-galactopyranoside, 19
",1,data/dev/EP3305797A1.txt,0
12268,"2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-α,β-D-galactopyranose, 21
",1,data/dev/EP3305797A1.txt,0
12271,"2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-α,β-L-arabinopyranoside, 22.
",1,data/dev/EP3305797A1.txt,0
12274,"2.2. Formation of trichloroacetimidate.
",0,data/dev/EP3305797A1.txt,1
12275,"2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-α,β-D-galactopyranoside-trichloroacetimidate, 23
",1,data/dev/EP3305797A1.txt,0
12281,"2.2. Glycosidation of trichloroacetimidate.
",1,data/dev/EP3305797A1.txt,0
12282,"Derived from galactose 25 and 26:
",1,data/dev/EP3305797A1.txt,0
12285,"<img> id-imgb0036.tif </img>
",0,data/dev/EP3305797A1.txt,1
12288,"<img> id-imgb0037.tif </img>
",0,data/dev/EP3305797A1.txt,1
12290,"Derivatives of L-arabinose 8 and 7:
",1,data/dev/EP3305797A1.txt,0
12292,"(R)-{1-3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-β-L-arabinopyranoside, 8.
",0,data/dev/EP3305797A1.txt,1
12293,"<img> id-imgb0038.tif </img>
",0,data/dev/EP3305797A1.txt,1
12295,"(R)-{1-3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-α-L-arabinopyranoside, 7.
",0,data/dev/EP3305797A1.txt,1
12296,"<img> id-imgb0039.tif </img>
",0,data/dev/EP3305797A1.txt,1
12298,"EXAMPLE 3. Selective deprotection of position 6.
",1,data/dev/EP3305797A1.txt,0
12299,"General procedure
",1,data/dev/EP3305797A1.txt,0
12301,"Alpha anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-α-D-galactopyranose, 27.
",1,data/dev/EP3305797A1.txt,0
12304,"Beta anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-β-D-galactopyranose, 28
",1,data/dev/EP3305797A1.txt,0
12307,"EXAMPLE 4. Deprotection of positions 3 and 4.
",1,data/dev/EP3305797A1.txt,0
12308,"General procedure
",1,data/dev/EP3305797A1.txt,0
12309,"A catalytic quantity of CSA is added to a solution of 3,4-isopropylene derived 27, 28, 7 or 8 (1 equiv.) in methanol and left stirring overnight. After that time the solvent is evaporated in vacuo and the residue obtained is purified by filtration with silica using ethyl as the eluent.
",1,data/dev/EP3305797A1.txt,0
12311,"Alpha anomer: (R)-{1-[3,4-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-α-D-galactopyranose, 4
",1,data/dev/EP3305797A1.txt,0
12314,"Beta anomer: (R)-{1-[3,4-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-β-D-galactopyranose, 3
",1,data/dev/EP3305797A1.txt,0
12326,"Alpha anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-(R)-[4,5-O-benzylidene]-α-D-galactopyranoside, 2
",1,data/dev/EP3305797A1.txt,0
12329,"Beta anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-(R)-[4,5-O-benzylidene]-β-D-D-galactopyranoside, 1
",1,data/dev/EP3305797A1.txt,0
12461,"Synthesis of C4-Modified SAHA Analogs.
",0,data/dev/US20180057448A1.txt,1
12491,"Concentration (M) & SAHA & 1a (methyl) & 1b (ethyl) & 1c (butyl) & 1d (hexyl) & 1e (phenyl) & 1f (benzyl)
",0,data/dev/US20180057448A1.txt,1
12758,"To remove the chiral auxiliary from (RS)-10 and (RR)-10, each diastereomer was reacted with lithium aluminum hydride, which produced alcohols (S)-11 and (R)-11 (Scheme 2). To assess the optical purity and enantiomeric excess (ee) of the alcohol intermediates (S)-11 and (R)-11, Mosher esters were synthesized by coupling each alcohol with (R)-(+)-α-Methoxy-α-trifluoromethylphenylacetic acid ((R)-MTPA) using EDCI and DMAP (Scheme S1).49 Analysis of the 1HNMR spectra showed that both Mosher esters were observed in high diastereomeric ratios (99:1 dr for (S)-11-(R)-MTPA, and 98:2 dr for (R)-11-(R)-MTPA), which implies that the alcohol intermediates (S)-11 and (R)-11 were obtained with high enantiomeric ratios (98% ee for (S)-11 and 96% ee (R)-11).
",0,data/dev/US20180057448A1.txt,1
12760,"To synthesize enantiopure C4-benzyl SAHA analogs (R)-1f and (S)-1f, both alcohols (S)-11 and (R)-11 were then converted to methanesulfonate esters, followed by substitution with dimethyl malonate to give diesters (R)-13 and (S)-13, respectively (Schemes 3). Krapcho decarboxylation afforded methyl ester intermediates (S)-14 and (R)-14. Cross metathesis of the methyl esters with N-phenyl acrylamide 15 using Grubbs' second generation catalyst afforded ester amides (S)-16 and (R)-16.5 Finally, reduction followed by substitution with hydroxyl amine gave both enantiomers of C4-benzyl SAHA analog, (R)-1f and (S)-1f (Schemes 3).
",0,data/dev/US20180057448A1.txt,1
12772,"II.A. Synthesis Procedures for 1a-1f
",1,data/dev/US20180057448A1.txt,0
